@NP	Tail nerve	1
@NP	electrical stimulation combined with scar ablation and neural transplantation	12
@NP	electrical stimulation	12
@NP	scar ablation and neural transplantation	49
@NP	scar ablation	49
@NP	neural transplantation	67
@NP	locomotor recovery	99
@NP	rats	121
@NP	chronically contused spinal cord ☆ Shu-xin Zhanga	131
@NP	chronically contused spinal cord	131
@NP	, Fengfa Huanga , Mary Gatesa , Eric G.	181
@NP	Fengfa Huanga , Mary Gatesa	183
@NP	Fengfa Huanga	183
@NP	Mary Gatesa	198
@NP	Holmberga	219
@NP	date	235
@NP	few treatment strategies	241
@NP	cellular transplantation	275
@NP	the chronically injured spinal cord	303
@NP	significant functional improvement	352
@NP	animal experiments	390
@NP	we	415
@NP	significant improvement of locomotor function	430
@NP	significant improvement	430
@NP	locomotor function	457
@NP	rats with chronic spinal cord injury -LRB- SCI -RRB-	492
@NP	rats	492
@NP	chronic spinal cord injury -LRB- SCI -RRB-	502
@NP	chronic spinal cord injury	502
@NP	SCI	530
@NP	the application	538
@NP	combination treatments with tail nerve electrical stimulation	557
@NP	combination treatments	557
@NP	tail nerve electrical stimulation	585
@NP	TANES	620
@NP	the central pattern generator	647
@NP	active	687
@NP	Contusion injury -LRB- 25 mm -RRB- to spinal cord T10	721
@NP	Contusion injury -LRB- 25 mm -RRB-	721
@NP	Contusion injury	721
@NP	25 mm	739
@NP	spinal cord T10	749
@NP	the NYU impactor device	787
@NP	female , adult Long -- Evans rats	814
@NP	female , adult Long	814
@NP	Evans rats	834
@NP	Rats in 2 of 4 groups with SCI	846
@NP	Rats	846
@NP	2 of 4 groups with SCI	854
@NP	2	854
@NP	4 groups with SCI	859
@NP	4 groups	859
@NP	SCI	873
@NP	basic treatments	886
@NP	scar ablation	904
@NP	transplantation of lamina propria of olfactory mucosa	930
@NP	transplantation	930
@NP	lamina propria of olfactory mucosa	949
@NP	lamina propria	949
@NP	olfactory mucosa	967
@NP	olfactory ensheathing cells	997
@NP	the lesion cavity	1030
@NP	6 weeks	1049
@NP	SCI	1063
@NP	Rats both with and without basic treatments	1068
@NP	Rats both	1068
@NP	Rats	1068
@NP	basic treatments	1095
@NP	one week after secondary surgery or 7 weeks	1136
@NP	one week	1136
@NP	secondary surgery or 7 weeks	1151
@NP	secondary surgery	1151
@NP	7 weeks	1172
@NP	SCI	1186
@NP	Sixteen weeks	1191
@NP	secondary surgery	1211
@NP	22 weeks	1232
@NP	SCI rats in two groups	1247
@NP	SCI rats	1247
@NP	two groups	1259
@NP	TANES	1280
@NP	their functional recovery	1309
@NP	those without TANES	1349
@NP	those	1349
@NP	TANES	1363
@NP	BBB	1390
@NP	open field rating scale -LRB- p < 0.01 -RRB-	1394
@NP	open field rating scale	1394
@NP	p < 0.01	1419
@NP	p	1419
@NP	< 0.01	1420
@NP	<	1420
@NP	0.01	1421
@NP	them , however	1434
@NP	them	1434
@NP	rats with basic treatments	1449
@NP	rats	1449
@NP	basic treatments	1459
@NP	better	1486
@NP	those	1498
@NP	basic treatments	1512
@NP	TANES	1530
@NP	the activity-dependent plasticity	1554
@NP	the injury level , which is critical for functional recovery	1594
@NP	the injury level	1594
@NP	functional recovery	1634
@NP	TANES	1669
@NP	axonal regeneration , including those from supraspinal level	1687
@NP	axonal regeneration	1687
@NP	those from supraspinal level	1718
@NP	those	1718
@NP	supraspinal level	1729
@NP	TANES	1754
@NP	considerable potential	1773
@NP	improvement of functional recovery	1810
@NP	improvement	1810
@NP	functional recovery	1825
@NP	rat model	1848
@NP	it	1859
@NP	a new strategy for chronic SCI	1876
@NP	a new strategy	1876
@NP	chronic SCI	1895
@NP	Introduction	1912
@NP	few treatment strategies	1932
@NP	cellular transplantation	1966
@NP	the chronically injured	1994
@NP	spinal cord	2040
@NP	significant functional improvement	2065
@NP	animal experiments -LRB- Barakat et al. , 2005 ; Tetzlaff et al. , 2011 -RRB-	2103
@NP	animal experiments	2103
@NP	Barakat	2123
@NP	et al. , 2005 ; Tetzlaff et al. , 2011	2131
@NP	et al.	2131
@NP	2005 ; Tetzlaff et al.	2139
@NP	2005	2139
@NP	Tetzlaff et al.	2145
@NP	Tetzlaff	2145
@NP	et al.	2154
@NP	2011	2162
@NP	the cellular transplantation	2181
@NP	therapies , lamina propria -LRB- LP -RRB-	2210
@NP	therapies	2210
@NP	lamina propria -LRB- LP -RRB-	2221
@NP	lamina propria	2221
@NP	LP	2237
@NP	derived olfactory ensheathing cells -LRB- OECs -RRB- and LP	2241
@NP	derived olfactory ensheathing cells -LRB- OECs -RRB-	2241
@NP	derived olfactory ensheathing cells	2241
@NP	OECs	2278
@NP	LP	2288
@NP	leading cell or tissue candidates for transplantation	2315
@NP	leading cell or tissue candidates	2315
@NP	transplantation	2353
@NP	the gap	2379
@NP	injured spinal cord due to their potential reparative properties and function	2390
@NP	injured spinal cord	2390
@NP	their potential reparative properties and function	2417
@NP	Boyd	2469
@NP	et al. , 2005	2474
@NP	et al.	2474
@NP	2005	2482
@NP	Lima et al. , 2009	2488
@NP	Lima	2488
@NP	et al. , 2009	2493
@NP	et al.	2493
@NP	2009	2501
@NP	Mackay-Sim et al. , 2008	2507
@NP	Mackay-Sim	2507
@NP	et al. , 2008	2518
@NP	et al.	2518
@NP	2008	2526
@NP	Richter et al. , 2005	2532
@NP	Richter	2532
@NP	et al. , 2005	2540
@NP	et al.	2540
@NP	2005	2548
@NP	our previous studies	2558
@NP	we	2580
@NP	an existing glial scar in chronically contused rat spinal cord	2604
@NP	an existing glial scar	2604
@NP	chronically contused rat spinal cord	2630
@NP	a rose Bengal-based phototoxic ablation method -LRB- Zhang et al. , 2007a -RRB-	2676
@NP	a rose Bengal-based phototoxic ablation method	2676
@NP	a rose	2676
@NP	Bengal-based phototoxic ablation method	2683
@NP	Zhang	2724
@NP	et al. , 2007a	2730
@NP	et al.	2730
@NP	2007a	2738
@NP	we	2756
@NP	the LP	2772
@NP	combination	2782
@NP	OEC	2808
@NP	the lesion cavity	2817
@NP	scar ablation	2853
@NP	Sixteen weeks	2868
@NP	combination treatment	2888
@NP	substantial tissue repair of damaged cord at the injury epicenter	2911
@NP	substantial tissue repair	2911
@NP	damaged cord at the injury epicenter	2940
@NP	damaged cord	2940
@NP	the injury epicenter	2956
@NP	1 -RRB- prominent development of endogenous repaired tissue	3005
@NP	prominent development	3008
@NP	endogenous repaired tissue	3033
@NP	endogenous	3033
@NP	tissue	3053
@NP	2 -RRB- disappearance of the lesion cavity	3061
@NP	disappearance	3064
@NP	the lesion cavity	3081
@NP	3 -RRB- integration of the repaired tissue with spared tissue	3104
@NP	integration	3107
@NP	the repaired tissue with spared tissue	3122
@NP	the repaired tissue	3122
@NP	spared tissue	3147
@NP	Anatomical tissue repair	3162
@NP	a more permissive environment	3196
@NP	the axons	3230
@NP	the injury site.However , remarkable tissue repair and axonal regeneration	3273
@NP	the injury site.However	3273
@NP	remarkable tissue repair	3298
@NP	axonal regeneration	3327
@NP	significant locomotor recovery -LRB- Zhang et al. , 2011a -RRB-	3365
@NP	significant locomotor recovery	3365
@NP	Zhang	3397
@NP	et al. , 2011a	3403
@NP	et al.	3403
@NP	2011a	3411
@NP	themain reasonmay	3419
@NP	the poor intrinsic , activity-dependent plasticity	3454
@NP	locomotor training	3515
@NP	the injury level of the spinal cord	3540
@NP	the injury level	3540
@NP	the spinal cord	3560
@NP	It	3577
@NP	gait	3607
@NP	sensory inputs and independently a central pattern generator -LRB- CPG -RRB-	3639
@NP	sensory inputs	3639
@NP	a central pattern generator -LRB- CPG -RRB-	3672
@NP	a central pattern generator	3672
@NP	CPG	3701
@NP	Ekeberg and Pearson , 2005 -RRB-	3707
@NP	Ekeberg and Pearson	3707
@NP	Ekeberg	3707
@NP	Pearson	3719
@NP	2005	3728
@NP	the sensory information	3745
@NP	a necessary component	3772
@NP	locomotor pattern generation -LRB- Norton and Mushahwar , 2010	3798
@NP	locomotor pattern generation -LRB- Norton and Mushahwar	3798
@NP	locomotor pattern generation	3798
@NP	Norton and Mushahwar	3828
@NP	Norton	3828
@NP	Mushahwar	3839
@NP	2010	3850
@NP	SCI	3867
@NP	plasticity below the lesion level of the spinal cord	3872
@NP	plasticity	3872
@NP	the lesion level of the spinal cord	3889
@NP	the lesion level	3889
@NP	the spinal cord	3909
@NP	place	3931
@NP	the optimization of the CPG expression	3947
@NP	the optimization	3947
@NP	the CPG expression	3967
@NP	plastic changes	3987
@NP	systems	4017
@NP	these systems	4037
@NP	a new dynamical control	4061
@NP	the spinal CPG -LRB- Rossignol et al. , 2007 -RRB-	4088
@NP	the spinal CPG	4088
@NP	Rossignol	4103
@NP	et al. , 2007	4113
@NP	et al.	4113
@NP	2007	4121
@NP	the spontaneous plasticity	4137
@NP	both the supraspinal and spinal levels	4174
@NP	SCI	4219
@NP	it	4224
@NP	functional recovery	4261
@NP	CPG-mediated plasticity	4287
@NP	functional recovery	4328
@NP	physical therapy	4373
@NP	rehabilitation approaches	4401
@NP	locomotor training	4451
@NP	techniques	4476
@NP	voluntary aspects of locomotion	4505
@NP	voluntary aspects	4505
@NP	locomotion	4526
@NP	endogenous spinal mechanisms -LRB- Rossignol et al. , 2007 -RRB-	4561
@NP	endogenous spinal mechanisms	4561
@NP	Rossignol	4591
@NP	et al. , 2007	4601
@NP	et al.	4601
@NP	2007	4609
@NP	Physical therapy	4616
@NP	a necessary mean	4656
@NP	the combining treatment	4677
@NP	chronic spinal cord injury	4704
@NP	the functional recovery	4742
@NP	both animal experiments and clinical trials	4769
@NP	animal experiments	4774
@NP	clinical trials	4797
@NP	Behrman and Harkema	4814
@NP	2000	4835
@NP	Dobkin et al. , 2007 ; Johston , 2001 ; Stevens et al. , 2006 ; Zhang et al.	4841
@NP	Dobkin	4841
@NP	et al. , 2007 ; Johston , 2001 ; Stevens et al. , 2006 ; Zhang et al.	4848
@NP	et al. , 2007	4848
@NP	et al.	4848
@NP	2007	4856
@NP	Johston , 2001	4862
@NP	Johston	4862
@NP	2001	4871
@NP	Stevens et al. , 2006	4877
@NP	Stevens	4877
@NP	et al. , 2006	4885
@NP	et al.	4885
@NP	2006	4893
@NP	Zhang et al.	4899
@NP	Zhang	4899
@NP	et al.	4905
@NP	2007b	4913
@NP	Evidence	4921
@NP	thatmovement of hind-limbs	4940
@NP	thatmovement	4940
@NP	hind-limbs	4956
@NP	the levels of NT-3 and BDNF	4980
@NP	the levels	4980
@NP	NT-3 and BDNF	4994
@NP	the motor neurons and muscle fibers	5011
@NP	the formation	5058
@NP	the dendritic tree and the plasticity of synaptic connection	5075
@NP	the dendritic tree	5075
@NP	the plasticity of synaptic connection	5098
@NP	the plasticity	5098
@NP	synaptic connection	5116
@NP	axonal regeneration	5145
@NP	the levels	5177
@NP	inhibitory molecules	5191
@NP	Gazula	5213
@NP	et al. , 2004 ; Ghiani et al. , 2007 ; Vaynman et al.	5220
@NP	et al. , 2004	5220
@NP	et al.	5220
@NP	2004	5228
@NP	Ghiani et al. , 2007	5234
@NP	Ghiani	5234
@NP	et al. , 2007	5241
@NP	et al.	5241
@NP	2007	5249
@NP	Vaynman et al.	5255
@NP	Vaynman	5255
@NP	et al.	5263
@NP	2003 , 2006 ; Wirz et al. , 2001 ; Ying et al.	5271
@NP	2003 , 2006	5271
@NP	2003	5271
@NP	2006	5277
@NP	Wirz et al. , 2001	5282
@NP	Wirz	5282
@NP	et al. , 2001	5287
@NP	et al.	5287
@NP	2001	5295
@NP	Ying et al.	5301
@NP	Ying	5301
@NP	et al.	5306
@NP	2003 , 2005	5314
@NP	2003	5314
@NP	2005	5320
@NP	fact	5330
@NP	the application of physical therapy in clinical trials and animal experiments	5336
@NP	the application	5336
@NP	physical therapy in clinical trials and animal experiments	5355
@NP	physical therapy	5355
@NP	clinical trials and animal experiments	5375
@NP	more and more attention	5428
@NP	Lima	5453
@NP	et al. , 2009 ; Tillakaratne et al. , 2010	5458
@NP	et al.	5458
@NP	2009 ; Tillakaratne et al.	5466
@NP	2009	5466
@NP	Tillakaratne et al.	5472
@NP	Tillakaratne	5472
@NP	et al.	5485
@NP	2010	5493
@NP	Functional electrical stimulation-based physical therapy	5500
@NP	Functional	5500
@NP	electrical stimulation-based physical therapy	5511
@NP	chronic SCI treatment	5579
@NP	decades in both clinical trials and animal experiments	5605
@NP	decades	5605
@NP	both clinical trials and animal experiments	5616
@NP	both clinical trials	5616
@NP	animal experiments	5641
@NP	a long history of safe use	5665
@NP	a long history	5665
@NP	safe use	5683
@NP	no major clinical problems	5697
@NP	Barbeau and Rossignol	5748
@NP	1994	5771
@NP	Barbeau	5777
@NP	et al. , 2002	5785
@NP	et al.	5785
@NP	2002	5793
@NP	Edgerton et al. , 2004	5799
@NP	Edgerton	5799
@NP	et al. , 2004	5808
@NP	et al.	5808
@NP	2004	5816
@NP	Hentall et al. , 2007	5822
@NP	Hentall	5822
@NP	et al. , 2007	5830
@NP	et al.	5830
@NP	2007	5838
@NP	Hesse et al. , 2004	5844
@NP	Hesse	5844
@NP	et al. , 2004	5850
@NP	et al.	5850
@NP	2004	5858
@NP	Johnston , 2006	5864
@NP	Johnston	5864
@NP	2006	5874
@NP	Rossignol et al.	5880
@NP	Rossignol	5880
@NP	et al.	5890
@NP	1996	5898
@NP	none	5914
@NP	we	5960
@NP	a technique , tail nerve electrical stimulation -LRB- TANES -RRB-	5973
@NP	a technique , tail nerve electrical stimulation	5973
@NP	TANES	6021
@NP	dependent physical therapy	6028
@NP	the activation of the CPG	6083
@NP	the activation	6083
@NP	the CPG	6101
@NP	the lesion level	6115
@NP	the tail nerves	6140
@NP	temporary body	6170
@NP	plantar	6201
@NP	characteristic features of active , alternative movement of left	6223
@NP	characteristic features	6223
@NP	active , alternative movement of left	6250
@NP	active , alternative movement	6250
@NP	right hind limbs	6287
@NP	coordination of front	6308
@NP	coordination	6308
@NP	front	6324
@NP	hind limbs	6330
@NP	rats with chronically contused spinal cord -LRB- Zhang et al. , 2010 -RRB-	6344
@NP	rats	6344
@NP	chronically contused spinal cord -LRB- Zhang et al. , 2010 -RRB-	6354
@NP	chronically contused spinal cord	6354
@NP	Zhang	6388
@NP	et al. , 2010	6394
@NP	et al.	6394
@NP	2010	6402
@NP	This	6409
@NP	an early study	6428
@NP	the spinally transected rats	6452
@NP	a strong tendency	6505
@NP	limbs	6548
@NP	tail pinch -LRB- Meisel and Rakerd , 1982 -RRB-	6561
@NP	tail pinch	6561
@NP	Meisel and Rakerd , 1982	6573
@NP	Meisel and Rakerd	6573
@NP	1982	6592
@NP	The TANES	6599
@NP	an effect	6623
@NP	that	6648
@NP	epidural stimulation	6656
@NP	the SCI patient	6691
@NP	full weight-bear standing	6718
@NP	assistance	6762
@NP	stimulation -LRB- Harkema et al. , 2011 -RRB-	6780
@NP	stimulation	6780
@NP	Harkema	6793
@NP	et al. , 2011	6801
@NP	et al.	6801
@NP	2011	6809
@NP	The noninvasive TANES	6816
@NP	more beneficial effects	6852
@NP	locomotor training	6879
@NP	other approaches	6903
@NP	treadmill training	6928
@NP	functional electrical stimulation	6951
@NP	de	6986
@NP	Leon	6989
@NP	et al. , 2002	6994
@NP	et al.	6994
@NP	2002	7002
@NP	Dietz et al. , 1997	7008
@NP	Dietz	7008
@NP	et al. , 1997	7014
@NP	et al.	7014
@NP	1997	7022
@NP	Field - Fote , 2000	7028
@NP	Field	7028
@NP	Fote , 2000	7035
@NP	Fote	7035
@NP	2000	7041
@NP	Gazula et al. , 2004	7047
@NP	Gazula	7047
@NP	et al. , 2004	7054
@NP	et al.	7054
@NP	2004	7062
@NP	Hidler , 2004	7068
@NP	Hidler	7068
@NP	2004	7076
@NP	Reinkensmeyer et al. , 2006	7082
@NP	Reinkensmeyer	7082
@NP	et al. , 2006	7096
@NP	et al.	7096
@NP	2006	7104
@NP	Van de Crommert et al. , 1998	7110
@NP	Van de Crommert	7110
@NP	et al. , 1998	7126
@NP	et al.	7126
@NP	1998	7134
@NP	We	7141
@NP	TANES	7161
@NP	the activity-dependent plasticity	7180
@NP	the activation of CPG , which would control the hind limb locomotion	7218
@NP	the activation	7218
@NP	CPG	7236
@NP	the hind limb locomotion	7261
@NP	The main purpose of the study	7287
@NP	The main purpose	7287
@NP	the study	7307
@NP	the effects of TANES	7332
@NP	the effects	7332
@NP	TANES	7347
@NP	a locomotor training paradigm on functional recovery	7356
@NP	a locomotor training paradigm	7356
@NP	functional recovery	7389
@NP	the basic treatment	7428
@NP	scar ablation and LP/OEC transplantation	7463
@NP	chronically contused spinal cord of rats	7507
@NP	chronically contused spinal cord	7507
@NP	rats	7543
@NP	Results Table 1 -- FB-labeled neurons in motor cortex and brainstem .	7553
@NP	Results Table 1	7553
@NP	Results	7553
@NP	Table 1	7561
@NP	FB-labeled neurons in motor cortex and brainstem	7571
@NP	FB-labeled neurons	7571
@NP	motor cortex and brainstem	7593
@NP	Fig. 1 -- Locomotor improvement by TANES .	7624
@NP	Fig. 1	7624
@NP	Locomotor improvement by TANES	7633
@NP	Locomotor improvement	7633
@NP	TANES	7658
@NP	Two or three weeks after TANES	7665
@NP	Two or three weeks	7665
@NP	TANES	7690
@NP	rats	7705
@NP	functional improvement	7724
@NP	the group	7750
@NP	basic treatments	7783
@NP	neither injury only control rats nor rats with basic treatments	7810
@NP	neither injury	7810
@NP	rats nor rats with basic treatments	7838
@NP	rats	7838
@NP	rats with basic treatments	7847
@NP	rats	7847
@NP	basic treatments	7857
@NP	notable improvement of functional recovery	7885
@NP	notable improvement	7885
@NP	functional recovery	7908
@NP	The difference of BBB scores between TANES rats and non-TANES rats	7929
@NP	The difference	7929
@NP	BBB scores between TANES rats and non-TANES rats	7947
@NP	BBB scores	7947
@NP	TANES rats and non-TANES rats	7966
@NP	TANES rats	7966
@NP	non-TANES rats	7981
@NP	p <	8028
@NP	p	8028
@NP	<	8029
@NP	0.01	8030
@NP	the end of this experiment	8039
@NP	the end	8039
@NP	this experiment	8050
@NP	0/6w : 6 weeks after contusion injury , i.e. , just before 2nd surgery ; 16/22	8067
@NP	0/6w	8067
@NP	6 weeks after contusion injury , i.e. , just before 2nd surgery	8073
@NP	6 weeks after contusion injury , i.e. ,	8073
@NP	6 weeks after contusion injury	8073
@NP	6 weeks	8073
@NP	contusion injury	8087
@NP	2nd surgery	8123
@NP	16/22	8136
@NP	16 weeks after 2nd surgery or 22 weeks after contusion injury	8143
@NP	16 weeks after 2nd surgery	8143
@NP	16 weeks	8143
@NP	2nd surgery	8158
@NP	22 weeks after contusion injury	8173
@NP	22 weeks	8173
@NP	contusion injury	8188
@NP	Fig. 2 -- Kinematic analysis of hind limb stepping cycle .	8207
@NP	Fig. 2	8207
@NP	Kinematic analysis of hind limb stepping cycle	8216
@NP	Kinematic analysis	8216
@NP	hind limb stepping cycle	8238
@NP	hind limb	8238
@NP	cycle	8257
@NP	A	8264
@NP	the bony landmarks of hind limbs related to the locomotion	8273
@NP	the bony landmarks	8273
@NP	hind limbs related to the locomotion	8295
@NP	hind limbs	8295
@NP	the locomotion	8317
@NP	B	8333
@NP	each phase	8342
@NP	consecutive	8356
@NP	cycles	8377
@NP	the beginning phase , middle phase , ending phase , and middle swing ,	8399
@NP	the beginning phase , middle phase ,	8399
@NP	the beginning phase	8399
@NP	middle phase	8420
@NP	phase , and middle swing ,	8441
@NP	phase	8441
@NP	middle swing	8452
@NP	the phase in stance	8477
@NP	the phase	8477
@NP	stance	8490
@NP	the normal rats and rats with full treatments -LRB- SCI+BT+TANES -RRB-	8508
@NP	the normal rats and rats	8508
@NP	full treatments -LRB- SCI+BT+TANES -RRB-	8538
@NP	full treatments	8538
@NP	SCI+BT+TANES	8555
@NP	stance with the support of the wall	8593
@NP	stance	8593
@NP	the support of the wall	8605
@NP	the support	8605
@NP	the wall	8620
@NP	their front limbs	8637
@NP	The horizontal line below each stick figure	8656
@NP	The horizontal line	8656
@NP	each stick figure	8682
@NP	the ground surface of the open field	8711
@NP	the ground surface	8711
@NP	the open field	8733
@NP	Fig. 3 -- Locomotor improvement .	8750
@NP	Fig. 3	8750
@NP	Locomotor improvement	8759
@NP	Representative photos saved from the video records	8782
@NP	Representative photos	8782
@NP	the video records	8815
@NP	the course of locomotor improvement	8838
@NP	the course	8838
@NP	locomotor improvement	8852
@NP	a typical rat in Group 4 -LRB- SCI+BT+TANES -RRB-	8879
@NP	a typical rat	8879
@NP	Group 4 -LRB- SCI+BT+TANES -RRB-	8896
@NP	Group 4	8896
@NP	SCI+BT+TANES	8905
@NP	combination treatments -LRB- 6 weeks after injury -RRB-	8927
@NP	combination treatments	8927
@NP	6 weeks after injury	8951
@NP	6 weeks	8951
@NP	injury	8965
@NP	the rat 's two hind limbs	8974
@NP	the rat 's	8974
@NP	the body weightmost of the time -LRB- arrowheads in A -RRB-	9017
@NP	the body weightmost	9017
@NP	the time -LRB- arrowheads in A -RRB-	9040
@NP	the time	9040
@NP	arrowheads in A	9050
@NP	arrowheads	9050
@NP	A	9064
@NP	Six weeks	9068
@NP	combination treatments	9084
@NP	the two hind limbs of the same rat	9108
@NP	the two hind limbs	9108
@NP	the same rat	9130
@NP	the body weight	9177
@NP	alternative movement of the two hind limbs	9198
@NP	alternative movement	9198
@NP	the two hind limbs	9222
@NP	the plantar	9248
@NP	arrows in B	9270
@NP	arrows	9270
@NP	B	9280
@NP	Typical posture of FL	9284
@NP	Typical posture	9284
@NP	FL	9303
@NP	HL	9306
@NP	front limbs , hind limbs	9310
@NP	front limbs	9310
@NP	hind limbs	9323
@NP	coordination	9335
@NP	14 weeks	9357
@NP	combination treatments of the same rat	9372
@NP	combination treatments	9372
@NP	the same rat	9398
@NP	C	9412
@NP	a normal rat -LRB- D -RRB-	9435
@NP	a normal rat	9435
@NP	D	9449
@NP	the postures of these two rats	9452
@NP	the postures	9452
@NP	these two rats	9468
@NP	the right front limb -LRB- RF -RRB-	9519
@NP	the right front limb	9519
@NP	RF	9541
@NP	hind limb -LRB- LH -RRB-	9554
@NP	hind limb	9554
@NP	LH	9565
@NP	the left front limb -LRB- LF -RRB- and right hind limb -LRB- RH -RRB-	9590
@NP	the left front limb -LRB- LF -RRB-	9590
@NP	the left front limb	9590
@NP	LF	9611
@NP	right hind limb -LRB- RH -RRB-	9619
@NP	right hind limb	9619
@NP	RH	9636
@NP	Fig. 4 -- Longitudinal profile of injury epicenter .	9669
@NP	Fig. 4	9669
@NP	Longitudinal profile of injury epicenter	9678
@NP	Longitudinal profile	9678
@NP	injury epicenter	9702
@NP	Representative photomicrographs	9720
@NP	longitudinal sections from a rat with basic treatments	9755
@NP	longitudinal sections	9755
@NP	a rat with basic treatments	9782
@NP	a rat	9782
@NP	basic treatments	9793
@NP	the lesion area	9815
@NP	tissue demarked by GFAP -LRB- arrows , A -RRB-	9842
@NP	tissue	9842
@NP	GFAP -LRB- arrows , A -RRB-	9861
@NP	GFAP	9861
@NP	arrows , A	9867
@NP	arrows	9867
@NP	A	9875
@NP	The lesion area	9879
@NP	p75NTR positive cells	9911
@NP	some tiny cysts -LRB- * , B -RRB-	9943
@NP	some tiny cysts	9943
@NP	*	9960
@NP	B	9963
@NP	Numerous axons -LRB- NF positive -RRB-	9967
@NP	Numerous axons	9967
@NP	NF	9983
@NP	the lesion area	10010
@NP	tissue -LRB- C -RRB-	10037
@NP	tissue	10037
@NP	C	10045
@NP	some of them	10049
@NP	some	10049
@NP	them	10057
@NP	the interfaces -LRB- broken lines -RRB- between spared tissue	10074
@NP	the interfaces -LRB- broken lines -RRB-	10074
@NP	the interfaces	10074
@NP	broken lines	10090
@NP	spared tissue	10112
@NP	lesion area in both rostral -LRB- D -RRB- and caudal -LRB- E -RRB-	10130
@NP	lesion area	10130
@NP	both rostral -LRB- D -RRB- and caudal -LRB- E -RRB-	10145
@NP	both rostral	10145
@NP	D	10159
@NP	caudal	10166
@NP	E	10174
@NP	the cord	10185
@NP	Scale bars : 0.5 mm -LRB- A , B , C -RRB- ; 0.2 mm -LRB- D , E -RRB- .	10195
@NP	Scale bars	10195
@NP	0.5 mm -LRB- A , B , C -RRB- ; 0.2 mm -LRB- D , E -RRB-	10207
@NP	0.5 mm -LRB- A , B , C -RRB-	10207
@NP	A , B , C	10214
@NP	0.2 mm -LRB- D , E -RRB-	10224
@NP	D , E	10231
@NP	D	10231
@NP	E	10234
@NP	Fig. 5 -- Tissue repair and glial scar disappearance .	10239
@NP	Fig. 5	10239
@NP	Tissue repair and glial scar disappearance	10248
@NP	Tissue repair	10248
@NP	glial scar disappearance	10266
@NP	A , B , C , and D	10292
@NP	B	10295
@NP	cross sections at the injury epicenter from different groups	10311
@NP	cross sections	10311
@NP	the injury epicenter from different groups	10329
@NP	the injury epicenter	10329
@NP	different groups	10355
@NP	the others in the same rows	10376
@NP	the others	10376
@NP	the same rows	10390
@NP	their local magnifications	10408
@NP	Panels in the left and middle columns	10450
@NP	Panels	10450
@NP	the left and middle columns	10460
@NP	the left	10460
@NP	middle columns	10473
@NP	H.E. staining	10492
@NP	those in the right column	10512
@NP	those	10512
@NP	the right column	10521
@NP	GFAP immunostaining	10542
@NP	tissue , lesion cavity ,	10570
@NP	tissue	10570
@NP	lesion cavity	10578
@NP	tissue	10606
@NP	the glial scars with sharp edge	10634
@NP	the glial scars	10634
@NP	sharp edge	10655
@NP	the arrows	10683
@NP	groups with basic treatments -LRB- rows C and D -RRB-	10698
@NP	groups	10698
@NP	basic treatments -LRB- rows C and D -RRB-	10710
@NP	basic treatments	10710
@NP	rows C and D	10728
@NP	the development	10743
@NP	repaired tissue and integration of repaired tissue with spared tissue	10762
@NP	repaired tissue and integration	10762
@NP	repaired tissue with spared tissue	10797
@NP	repaired tissue	10797
@NP	spared tissue	10818
@NP	the lesion cavities and glial scars with sharp edge	10863
@NP	the lesion cavities	10863
@NP	glial scars with sharp edge	10887
@NP	glial scars	10887
@NP	sharp edge	10904
@NP	SCI	10938
@NP	spinal cord	10943
@NP	injury	10955
@NP	BT : basic treatments ; TANES : tail nerve electrical stimulation ; ST	10963
@NP	BT	10963
@NP	basic treatments ; TANES : tail nerve electrical stimulation	10967
@NP	basic treatments ; TANES	10967
@NP	basic treatments	10967
@NP	TANES	10985
@NP	tail nerve electrical stimulation	10992
@NP	tail nerve	10992
@NP	electrical stimulation	11003
@NP	ST	11027
@NP	tissue	11038
@NP	DR : dorsal root	11046
@NP	DR	11046
@NP	dorsal root	11050
@NP	VR : ventral root	11063
@NP	VR	11063
@NP	ventral root	11067
@NP	Scale bars : 0.5 mm -LRB- left column -RRB- , 50 μm -LRB- the rest -RRB- .	11081
@NP	Scale bars	11081
@NP	0.5 mm -LRB- left column -RRB- , 50 μm -LRB- the rest -RRB-	11093
@NP	0.5 mm	11093
@NP	left column	11100
@NP	50 μm -LRB- the rest -RRB-	11114
@NP	the rest	11121
@NP	Fig. 6 -- Quantitative analysis of tissue repair .	11133
@NP	Fig. 6	11133
@NP	Quantitative analysis of tissue repair	11142
@NP	Quantitative analysis	11142
@NP	tissue repair	11167
@NP	The percentages	11182
@NP	spared tissue	11201
@NP	tissue and lesion cavity	11225
@NP	the whole area of a cross section	11253
@NP	the whole area	11253
@NP	a cross section	11271
@NP	the injury epicenter in each group	11290
@NP	the injury epicenter	11290
@NP	each group	11314
@NP	The development of repaired tissue	11336
@NP	The development	11336
@NP	repaired tissue	11355
@NP	the reduction of lesion cavities	11400
@NP	the reduction	11400
@NP	lesion cavities	11417
@NP	groups	11436
@NP	basic treatments -LRB- BT -RRB-	11448
@NP	basic treatments	11448
@NP	BT	11466
@NP	the control group	11490
@NP	p <	11510
@NP	p	11510
@NP	<	11511
@NP	0.05	11512
@NP	p <	11520
@NP	p	11520
@NP	<	11521
@NP	0.01	11522
@NP	Fig. 7 -- P0-positive myelination .	11529
@NP	Fig. 7	11529
@NP	P0-positive myelination	11538
@NP	Representative photomicrographs	11563
@NP	A , H.E. staining ; B and C , P0-immunostaining	11596
@NP	A	11596
@NP	H.E. staining ; B and C	11599
@NP	H.E. staining	11599
@NP	B and C	11614
@NP	P0-immunostaining	11623
@NP	a rat in Group 4	11647
@NP	a rat	11647
@NP	Group 4	11656
@NP	SCI+BT+TANES	11665
@NP	the P0-positive myelin sheaths	11689
@NP	tissue	11744
@NP	tissue -LRB- ST -RRB- , besides in the dorsal roots -LRB- DR -RRB-	11762
@NP	tissue -LRB- ST -RRB-	11762
@NP	tissue	11762
@NP	ST	11770
@NP	the dorsal roots -LRB- DR -RRB-	11786
@NP	the dorsal roots	11786
@NP	DR	11804
@NP	The area of repaired tissue marked by asterisks -LRB- * -RRB-	11827
@NP	The area	11827
@NP	repaired tissue marked by asterisks -LRB- * -RRB-	11839
@NP	repaired tissue	11839
@NP	asterisks -LRB- * -RRB-	11865
@NP	asterisks	11865
@NP	numerous P0-positive myelin sheaths , which are magnified in C.	11888
@NP	numerous P0-positive myelin sheaths	11888
@NP	C.	11948
@NP	The P0-positive myelin sheaths	11951
@NP	small circles or dots	11992
@NP	brown	12017
@NP	some of them	12028
@NP	some	12028
@NP	them	12036
@NP	the arrowheads	12058
@NP	Most of nuclei stained by hematoxylin	12074
@NP	Most	12074
@NP	nuclei stained by hematoxylin	12082
@NP	nuclei	12082
@NP	hematoxylin	12100
@NP	Schwann cells	12126
@NP	Histogram -LRB- D -RRB-	12141
@NP	Histogram	12141
@NP	D	12151
@NP	the average numbers -LRB- Mean ± SEM -RRB-	12160
@NP	the average numbers	12160
@NP	Mean ± SEM	12181
@NP	P0-positive myelin sheaths in individual groups	12194
@NP	P0-positive myelin sheaths	12194
@NP	individual groups	12224
@NP	Scale bars : 0.5 mm -LRB- A , B -RRB- , 50 μm -LRB- C -RRB- .	12243
@NP	Scale bars	12243
@NP	0.5 mm -LRB- A , B -RRB- , 50 μm -LRB- C -RRB-	12255
@NP	0.5 mm	12255
@NP	A , B	12262
@NP	A	12262
@NP	B	12265
@NP	50 μm -LRB- C -RRB-	12269
@NP	C	12276
@NP	The p values	12280
@NP	the histogram	12315
@NP	Fig. 8 -- Quantitative analysis of FB labeled neurons .	12331
@NP	Fig. 8	12331
@NP	Quantitative analysis of FB labeled neurons	12340
@NP	Quantitative analysis	12340
@NP	FB labeled neurons	12365
@NP	FB	12365
@NP	neurons	12376
@NP	Representative photomicrograph -LRB- A -RRB-	12385
@NP	Representative photomicrograph	12385
@NP	A	12417
@NP	the neurons	12426
@NP	the brain	12441
@NP	the retrograde tracer , fast blue , observed under the fluorescence microscope	12462
@NP	the retrograde tracer	12462
@NP	the fluorescence microscope	12511
@NP	Some labeled neuronal cell bodies	12540
@NP	Some	12540
@NP	neuronal cell bodies	12553
@NP	the arrows	12589
@NP	Scale bar : 400 μm .	12601
@NP	Scale bar	12601
@NP	400 μm	12612
@NP	Histograms	12620
@NP	the number of FB-labeled neurons -LRB- Mean ± SEM -RRB-	12636
@NP	the number	12636
@NP	FB-labeled neurons -LRB- Mean ± SEM -RRB-	12650
@NP	FB-labeled neurons	12650
@NP	Mean ± SEM	12670
@NP	Mean	12670
@NP	± SEM	12674
@NP	motor cortex -LRB- B -RRB-	12685
@NP	motor cortex	12685
@NP	B	12699
@NP	red nucleus -LRB- C -RRB-	12703
@NP	red nucleus	12703
@NP	C	12716
@NP	lateral vestibular nucleus -LRB- D -RRB-	12720
@NP	lateral vestibular nucleus	12720
@NP	D	12748
@NP	reticular formation -LRB- E -RRB-	12752
@NP	reticular formation	12752
@NP	E	12773
@NP	raphe nucleus -LRB- F -RRB-	12777
@NP	raphe nucleus	12777
@NP	F	12792
@NP	locus coeruleus -LRB- G -RRB-	12796
@NP	locus coeruleus	12796
@NP	G	12813
@NP	the total number -LRB- H -RRB- in different groups	12820
@NP	the total number -LRB- H -RRB-	12820
@NP	the total number	12820
@NP	H	12838
@NP	different groups	12844
@NP	details	12866
@NP	Table 1	12878
@NP	The p values	12888
@NP	each individual histogram	12923
@NP	Fig. 9 -- Relationship between FB-labeled neurons and BBB scores .	12951
@NP	Fig. 9	12951
@NP	Relationship between FB-labeled neurons and BBB scores	12960
@NP	Relationship	12960
@NP	FB-labeled neurons and BBB scores	12981
@NP	FB-labeled neurons	12981
@NP	BBB scores	13004
@NP	The total numbers of FB-labeled neurons from each case with FB tracing	13016
@NP	The total numbers	13016
@NP	FB-labeled neurons from each case with FB tracing	13037
@NP	FB-labeled neurons	13037
@NP	each case with FB tracing	13061
@NP	each case	13061
@NP	FB tracing	13076
@NP	FB	13076
@NP	the BBB scores	13108
@NP	Linear regression analysis	13124
@NP	a significant positive correlation	13157
@NP	FB-labeled neurons and BBB scores -LRB- r = 0.89 , n = 23 , p < 0.001 -RRB-	13200
@NP	FB-labeled neurons	13200
@NP	BBB scores -LRB- r = 0.89 , n = 23 , p < 0.001 -RRB-	13223
@NP	BBB scores	13223
@NP	r = 0.89 , n = 23 , p < 0.001	13235
@NP	r = 0.89	13235
@NP	r	13235
@NP	n = 23	13243
@NP	n	13243
@NP	23	13245
@NP	p < 0.001	13249
@NP	p <	13249
@NP	p	13249
@NP	0.001	13251
@NP	2.1	13260
@NP	Significant improvement of functional recovery	13265
@NP	Significant improvement	13265
@NP	functional recovery	13292
@NP	our previous observation -LRB- Zhang et al. , 2011a -RRB-	13323
@NP	our previous observation	13323
@NP	Zhang	13349
@NP	et al. , 2011a	13355
@NP	et al.	13355
@NP	2011a	13363
@NP	rats in two control groups , i.e.	13371
@NP	rats	13371
@NP	two control groups	13379
@NP	Group 1 -LRB- SCI Control : 9.21 ± 0.22 to 9.38 ± 0.32 -RRB-	13405
@NP	Group 1	13405
@NP	SCI Control : 9.21 ± 0.22 to 9.38 ± 0.32	13414
@NP	SCI Control	13414
@NP	9.21 ± 0.22 to 9.38 ± 0.32	13427
@NP	9.21	13427
@NP	± 0.22 to 9.38 ± 0.32	13431
@NP	Group 3 -LRB- SCI+BT : 9.30 ± 0.33 to 9.60 ± 0.33 -RRB-	13455
@NP	Group 3	13455
@NP	SCI+BT : 9.30 ± 0.33 to 9.60 ± 0.33	13464
@NP	SCI+BT	13464
@NP	9.30 ± 0.33 to 9.60 ± 0.33	13472
@NP	9.30	13472
@NP	± 0.33 to 9.60 ± 0.33	13476
@NP	their BBB scores	13509
@NP	the beginning -LRB- 6 weeks after contusion -RRB-	13548
@NP	the beginning	13548
@NP	6 weeks after contusion	13563
@NP	6 weeks	13563
@NP	contusion	13577
@NP	the end	13591
@NP	the experiment	13602
@NP	22 weeks after injury or 16 weeks after secondary surgery	13618
@NP	22 weeks after injury	13618
@NP	22 weeks	13618
@NP	injury	13633
@NP	16 weeks after secondary surgery	13643
@NP	16 weeks	13643
@NP	secondary surgery	13658
@NP	The slight increase in their BBB scores	13678
@NP	The slight increase	13678
@NP	their BBB scores	13701
@NP	the limited endogenous ability of tissue repair and functional recovery	13736
@NP	endogenous ability of tissue repair	13748
@NP	endogenous ability	13748
@NP	tissue repair	13770
@NP	Beattie	13809
@NP	et al. , 1997	13817
@NP	et al.	13817
@NP	1997	13825
@NP	there	13836
@NP	no significant difference between these two groups	13845
@NP	no significant difference	13845
@NP	these two groups	13879
@NP	that at the beginning	13917
@NP	that	13917
@NP	the beginning	13925
@NP	the end of the experiment of each group -LRB- Fig. 1 -RRB-	13943
@NP	the end	13943
@NP	the experiment of each group -LRB- Fig. 1 -RRB-	13954
@NP	the experiment	13954
@NP	each group -LRB- Fig. 1 -RRB-	13972
@NP	each group	13972
@NP	Fig. 1	13984
@NP	rats	14008
@NP	TANES	14018
@NP	both Group 2 -LRB- SCI+TANES : 9.33 ± 0.22 to 10.67 ± 0.45 -RRB- and Group 4	14027
@NP	Group 2 -LRB- SCI+TANES : 9.33 ± 0.22 to 10.67 ± 0.45 -RRB-	14032
@NP	Group 2	14032
@NP	SCI+TANES : 9.33 ± 0.22 to 10.67 ± 0.45	14041
@NP	SCI+TANES	14041
@NP	9.33 ± 0.22 to 10.67 ± 0.45	14052
@NP	9.33	14052
@NP	± 0.22 to 10.67 ± 0.45	14056
@NP	Group 4	14081
@NP	SCI+BT+TANES : 9.33 ± 0.20 to 11.46 ± 0.47	14090
@NP	SCI+BT+TANES	14090
@NP	9.33 ± 0.20 to 11.46 ± 0.47	14104
@NP	9.33	14104
@NP	± 0.20 to 11.46 ± 0.47	14108
@NP	improvement of functional recovery	14145
@NP	improvement	14145
@NP	functional recovery	14160
@NP	2 or 3 weeks	14180
@NP	physical therapy	14199
@NP	the end of the experiment	14228
@NP	the end	14228
@NP	the experiment	14239
@NP	most of the rats with TANES	14255
@NP	most	14255
@NP	the rats with TANES	14263
@NP	the rats	14263
@NP	TANES	14277
@NP	obvious improvement of functional recovery	14290
@NP	obvious improvement	14290
@NP	functional recovery	14313
@NP	The average BBB scores	14334
@NP	Group 2 -LRB- p < 0.05 -RRB- and Group 4 -LRB- p < 0.01 -RRB-	14360
@NP	Group 2	14360
@NP	p < 0.05	14369
@NP	p	14369
@NP	< 0.05	14370
@NP	<	14370
@NP	0.05	14371
@NP	Group 4	14381
@NP	p < 0.01	14390
@NP	p	14390
@NP	< 0.01	14391
@NP	<	14391
@NP	0.01	14392
@NP	that of both Groups	14428
@NP	that	14428
@NP	both Groups	14436
@NP	1 and 3	14448
@NP	the end of the experiment	14459
@NP	the end	14459
@NP	the experiment	14470
@NP	addition	14489
@NP	comparison	14499
@NP	BBB scores at the beginning and end of the experiments in these two groups	14513
@NP	BBB scores	14513
@NP	the beginning and end of the experiments in these two groups	14527
@NP	the beginning and end	14527
@NP	the experiments in these two groups	14552
@NP	the experiments	14552
@NP	these two groups	14571
@NP	p < 0.01	14618
@NP	p	14618
@NP	< 0.01	14619
@NP	<	14619
@NP	0.01	14620
@NP	Fig. 1	14627
@NP	We	14636
@NP	the average BBB scores in Group 2 -LRB- SCI+TANES -RRB-	14655
@NP	the average BBB scores in Group 2	14655
@NP	the average BBB scores	14655
@NP	Group 2	14681
@NP	SCI+TANES	14690
@NP	increase with a significant difference	14701
@NP	increase	14701
@NP	a significant difference	14715
@NP	eight weeks	14740
@NP	treatments	14758
@NP	a plateau	14787
@NP	the end of the observation at 22 weeks	14803
@NP	the end	14803
@NP	the observation at 22 weeks	14814
@NP	the observation	14814
@NP	22 weeks	14833
@NP	contusion	14848
@NP	the average BBB scores in Group 4 -LRB- SCI+BT+TANES -RRB-	14868
@NP	the average BBB scores in Group 4	14868
@NP	the average BBB scores	14868
@NP	Group 4	14894
@NP	SCI+BT+TANES	14903
@NP	14 weeks	14939
@NP	the physical therapy treatment -LRB- Fig. 1 -RRB-	14954
@NP	the physical therapy treatment	14954
@NP	Fig. 1	14986
@NP	Qualitative kinematic analysis -LRB- Fig. 2 -RRB-	14995
@NP	Qualitative kinematic analysis	14995
@NP	Fig. 2	15027
@NP	normal rats	15050
@NP	the stepping cycle	15062
@NP	weightsupported hind limb plantar	15102
@NP	pattern	15145
@NP	The knee	15154
@NP	the ground	15183
@NP	The ankle	15195
@NP	the plantae	15227
@NP	the longitudinal axis of the body	15255
@NP	the longitudinal axis	15255
@NP	the body	15280
@NP	the swing phase	15293
@NP	the toes	15309
@NP	no contact with the ground surface	15323
@NP	no contact	15323
@NP	the ground surface	15339
@NP	addition	15362
@NP	the normal rat	15372
@NP	the support of front limbs	15405
@NP	the support	15405
@NP	front limbs	15420
@NP	the wall	15440
@NP	rats with chronic SCI -LRB- SCI Control -RRB-	15459
@NP	rats with chronic SCI	15459
@NP	rats	15459
@NP	chronic SCI	15469
@NP	SCI Control	15482
@NP	a certain degree of spontaneous recovery of function	15500
@NP	a certain degree	15500
@NP	spontaneous recovery of function	15520
@NP	spontaneous recovery	15520
@NP	function	15544
@NP	the knee always touches the ground and the ankle	15554
@NP	the knee	15554
@NP	touches the ground and the ankle	15570
@NP	touches	15570
@NP	the ground and the ankle	15578
@NP	the ground	15578
@NP	the ankle	15593
@NP	Rats with basic treatments -LRB- SCI+BT -RRB-	15639
@NP	Rats	15639
@NP	basic treatments -LRB- SCI+BT -RRB-	15649
@NP	basic treatments	15649
@NP	SCI+BT	15667
@NP	their ankles	15692
@NP	the body weight	15725
@NP	stance	15744
@NP	their knees	15756
@NP	the ground	15786
@NP	their hind limbs	15801
@NP	their body weight	15842
@NP	continuous stepping	15867
@NP	continuous	15867
@NP	the group of rats with full treatment -LRB- SCI+BT+TANES -RRB-	15891
@NP	the group	15891
@NP	rats with full treatment -LRB- SCI+BT+TANES -RRB-	15904
@NP	rats	15904
@NP	full treatment -LRB- SCI+BT+TANES -RRB-	15914
@NP	full treatment	15914
@NP	SCI+BT+TANES	15930
@NP	their hind limbs	15945
@NP	the body weight	15982
@NP	plantar stepping consistently	16003
@NP	plantar	16003
@NP	Their knees	16034
@NP	the ground	16062
@NP	The ankles	16074
@NP	normal rats	16143
@NP	they	16156
@NP	the front limbs holding the wall	16184
@NP	the front limbs	16184
@NP	the wall	16208
@NP	normal rats	16255
@NP	their hind limbs	16277
@NP	the ground	16306
@NP	the swing	16324
@NP	their behavior	16347
@NP	the normal rats	16381
@NP	addition	16401
@NP	the kinematic analysis	16411
@NP	rats without basic treatments but with TANES also	16448
@NP	rats	16448
@NP	basic treatments	16461
@NP	TANES	16487
@NP	significant improvement of locomotor pattern	16503
@NP	significant improvement	16503
@NP	locomotor pattern	16530
@NP	SCI control rats	16567
@NP	this group	16594
@NP	rats	16644
@NP	full treatments	16654
@NP	A typical ratwith significant functional recovery fromGroup 4	16671
@NP	A typical ratwith significant functional recovery fromGroup	16671
@NP	4	16731
@NP	SCI+BT+TANES	16734
@NP	Fig. 3	16761
@NP	the secondary surgery	16776
@NP	this ratwas unable	16799
@NP	her bodyweight	16829
@NP	her two hind limbs	16849
@NP	6 weeks after treatments , this rat	16892
@NP	6 weeks	16892
@NP	treatments , this rat	16906
@NP	treatments	16906
@NP	this rat	16918
@NP	prominent improvement of locomotor function in her two hind limbs	16934
@NP	prominent improvement	16934
@NP	locomotor function in her two hind limbs	16959
@NP	locomotor function	16959
@NP	her two hind limbs	16981
@NP	bodyweight supported stepping characterized by left	17017
@NP	bodyweight	17017
@NP	right alternation and tail	17069
@NP	right alternation	17069
@NP	tail	17091
@NP	14 weeks after treatment	17103
@NP	14 weeks	17103
@NP	treatment	17118
@NP	this rat	17129
@NP	consistent coordination of front	17145
@NP	consistent coordination	17145
@NP	front	17172
@NP	hind limb movement , when compared with a normal rat	17178
@NP	hind limb movement	17178
@NP	a normal rat	17217
@NP	2.2	17231
@NP	Tissue repair and integration	17236
@NP	the injury epicenter	17269
@NP	the general situation of tissue repair and axonal regeneration	17313
@NP	the general situation	17313
@NP	tissue repair and axonal regeneration	17338
@NP	tissue repair	17338
@NP	axonal regeneration	17356
@NP	the injury epicenter	17379
@NP	3 rats	17401
@NP	4 weeks	17422
@NP	basic treatments and the spinal cords	17436
@NP	basic treatments	17436
@NP	the spinal cords	17457
@NP	longitudinal section	17493
@NP	The sections	17515
@NP	primary antibodies GFAP , p75NTR and neurofilament -LRB- NF -RRB-	17552
@NP	primary antibodies GFAP	17552
@NP	p75NTR and neurofilament -LRB- NF -RRB-	17577
@NP	p75NTR and neurofilament	17577
@NP	NF	17603
@NP	The results	17622
@NP	the spared tissue and lesion area	17647
@NP	the lesion area	17682
@NP	p75NTR positive cells	17714
@NP	they	17748
@NP	transplanted OECs or host Schwann cells , which contribute to the tissue repair	17764
@NP	transplanted OECs	17764
@NP	host Schwann cells , which contribute to the tissue repair	17785
@NP	host Schwann cells	17785
@NP	the tissue repair	17825
@NP	addition	17847
@NP	numerous axons	17857
@NP	the lesion area -LRB- regenerating -RRB-	17886
@NP	the lesion area	17886
@NP	the spared tissue	17931
@NP	many of them	17950
@NP	many	17950
@NP	them	17958
@NP	the boundary	17990
@NP	the spared tissue and lesion area in both rostral and caudal ends of the cord	18011
@NP	the spared tissue and lesion area	18011
@NP	both rostral and caudal ends	18048
@NP	rostral	18053
@NP	caudal ends	18065
@NP	the cord	18080
@NP	these regenerating axons	18106
@NP	lesion area	18147
@NP	tissue -LRB- Fig. 4 -RRB-	18169
@NP	tissue	18169
@NP	Fig. 4	18177
@NP	Similar	18186
@NP	our previous observation -LRB- Zhang et al. , 2011a -RRB- , in Group 1	18197
@NP	our previous observation	18197
@NP	Zhang	18223
@NP	et al. , 2011a	18229
@NP	et al.	18229
@NP	2011a	18237
@NP	Group 1	18248
@NP	SCI Control	18257
@NP	the present study	18273
@NP	the repaired tissue -LRB- 43.36 ± 5.02 % -RRB- and the lesion cavity	18291
@NP	the repaired tissue -LRB- 43.36 ± 5.02 % -RRB-	18291
@NP	the repaired tissue	18291
@NP	43.36 ± 5.02 %	18312
@NP	43.36	18312
@NP	± 5.02 %	18317
@NP	the lesion cavity	18329
@NP	42.29 ± 6.00 %	18348
@NP	42.29	18348
@NP	± 6.00 %	18353
@NP	prominent change	18380
@NP	size	18400
@NP	22 weeks	18405
@NP	injury	18420
@NP	the glial scar , which is located at the inner edge of the spared tissue	18428
@NP	the glial scar	18428
@NP	the inner edge of the spared tissue	18464
@NP	the inner edge	18464
@NP	the spared tissue	18482
@NP	GFAP immunoreaction	18517
@NP	Group 2 -LRB- SCI+TANES -RRB-	18564
@NP	Group 2	18564
@NP	SCI+TANES	18573
@NP	the repaired tissue	18585
@NP	expanded -LRB- 60.31 ± 6.29 % -RRB-	18624
@NP	expanded	18624
@NP	60.31 ± 6.29 %	18634
@NP	60.31	18634
@NP	± 6.29 %	18639
@NP	the lesion cavity -LRB- 28.00 ± 7.76 % -RRB- and glial scarwith sharp edge	18652
@NP	the lesion cavity -LRB- 28.00 ± 7.76 % -RRB-	18652
@NP	the lesion cavity	18652
@NP	28.00 ± 7.76 %	18671
@NP	28.00 ±	18671
@NP	7.76 %	18677
@NP	glial scarwith sharp edge	18688
@NP	Group 3 -LRB- SCI+BT -RRB- and Group 4 -LRB- SCI+BT+TANES -RRB-	18733
@NP	Group 3	18733
@NP	SCI+BT	18742
@NP	Group 4	18754
@NP	SCI+BT+TANES	18763
@NP	the expanded	18778
@NP	tissue -LRB- 87.81 ± 0.99 % in Group 3	18800
@NP	tissue -LRB- 87.81 ± 0.99 %	18800
@NP	tissue	18800
@NP	87.81 ± 0.99 %	18808
@NP	87.81 ±	18808
@NP	0.99 %	18814
@NP	Group 3	18823
@NP	87.62	18832
@NP	Group	18847
@NP	almost completely	18856
@NP	the damaged area	18883
@NP	resulting in nearly the disappearance of the lesion cavity -LRB- 2.42 ± 0.92 %	18901
@NP	resulting	18901
@NP	nearly the disappearance of the lesion cavity -LRB- 2.42 ± 0.92 %	18914
@NP	nearly the disappearance	18914
@NP	the lesion cavity -LRB- 2.42 ± 0.92 %	18942
@NP	the lesion cavity -LRB- 2.42 ±	18942
@NP	the lesion cavity	18942
@NP	2.42 ±	18961
@NP	2.42	18961
@NP	±	18965
@NP	Group 3 ; 1.97	18975
@NP	± 1.69 %	18988
@NP	Group	18998
@NP	the integration of	19011
@NP	the integration	19011
@NP	tissue	19039
@NP	tissue ; simultaneously	19058
@NP	tissue	19058
@NP	almost no more glial scar with sharp edge	19082
@NP	almost no more glial scar	19082
@NP	sharp edge	19113
@NP	the spared tissues	19155
@NP	size	19204
@NP	the entire period of experiment -LRB- Figs. 5 and 6 -RRB-	19216
@NP	the entire period	19216
@NP	experiment -LRB- Figs. 5 and 6 -RRB-	19237
@NP	experiment	19237
@NP	Figs. 5 and 6	19249
@NP	Figs. 5	19249
@NP	6	19261
@NP	2.3	19265
@NP	Prominent enhancement of P0-positive myelination Monoclonal antibody P0	19270
@NP	Prominent enhancement	19270
@NP	P0-positive myelination Monoclonal antibody P0	19295
@NP	the myelin sheaths	19358
@NP	the characteristics of peripheral nerves	19382
@NP	the characteristics	19382
@NP	peripheral nerves	19405
@NP	the injury site	19426
@NP	these P0-positive myelin sheaths	19462
@NP	the repaired tissue , lesion cavity	19509
@NP	the repaired tissue	19509
@NP	lesion cavity	19530
@NP	tissue -LRB- Figs. 7A -- C -RRB-	19555
@NP	tissue	19555
@NP	Figs. 7A -- C	19563
@NP	Figs. 7A	19563
@NP	C	19572
@NP	They	19576
@NP	the host Schwann cells	19600
@NP	The myelinated fibers	19624
@NP	regenerating axons -LRB- in the repaired tissue -RRB-	19658
@NP	regenerating axons	19658
@NP	the repaired tissue	19681
@NP	axons -LRB- in the spared tissue -RRB-	19718
@NP	axons	19718
@NP	the spared tissue	19728
@NP	there	19760
@NP	axons	19797
@NP	The counts of P0-positive myelin sheaths in each group	19804
@NP	The counts	19804
@NP	P0-positive myelin sheaths in each group	19818
@NP	P0-positive myelin sheaths	19818
@NP	each group	19848
@NP	Mean ± SEM	19872
@NP	Group 1	19882
@NP	SCI control	19891
@NP	1747 ± 255 -LRB- n = 5 -RRB-	19905
@NP	1747	19905
@NP	± 255 -LRB- n = 5 -RRB-	19909
@NP	± 255	19909
@NP	n	19915
@NP	5	19917
@NP	Group 2 -LRB- SCI+TANES -RRB-	19921
@NP	Group 2	19921
@NP	SCI+TANES	19930
@NP	3561 ± 1301 -LRB- n = 4 -RRB-	19942
@NP	3561	19942
@NP	± 1301 -LRB- n = 4 -RRB-	19946
@NP	± 1301	19946
@NP	n	19952
@NP	4	19954
@NP	Group 3 -LRB- SCI+BT -RRB-	19958
@NP	Group 3	19958
@NP	SCI+BT	19967
@NP	3363 ± 485 -LRB- n = 4 -RRB-	19976
@NP	3363	19976
@NP	± 485 -LRB- n = 4 -RRB-	19980
@NP	± 485	19980
@NP	n	19986
@NP	4	19988
@NP	Group 4 -LRB- SCI+BT+TANES -RRB-	19992
@NP	Group 4	19992
@NP	SCI+BT+TANES	20001
@NP	5031 ± 1571 -LRB- n = 4 -RRB-	20016
@NP	5031	20016
@NP	± 1571 -LRB- n = 4 -RRB-	20020
@NP	± 1571	20020
@NP	n	20027
@NP	4	20029
@NP	Differences between Group 3 and Group 1 , and between Group 4 and Group 1	20033
@NP	Differences	20033
@NP	Group 3 and Group 1	20053
@NP	Group 3	20053
@NP	Group 1	20065
@NP	Group 4 and Group 1	20086
@NP	Group 4	20086
@NP	Group 1	20098
@NP	p < 0.05	20137
@NP	p	20137
@NP	< 0.05	20138
@NP	<	20138
@NP	0.05	20139
@NP	Fig. 7D	20146
@NP	2.4	20156
@NP	axonal regeneration of supraspinal neurons	20170
@NP	axonal regeneration	20170
@NP	supraspinal neurons	20193
@NP	the 4 standard groups	20221
@NP	one additional group -LRB- SCI 3w , 3 weeks after contusion -RRB-	20244
@NP	one additional group	20244
@NP	SCI 3w , 3 weeks after contusion	20266
@NP	SCI 3w	20266
@NP	3 weeks after contusion	20274
@NP	3 weeks	20274
@NP	contusion	20288
@NP	sub-acute injury	20304
@NP	the number	20368
@NP	the supraspinal neurons , whose axons survived the contusion injury	20382
@NP	the supraspinal neurons	20382
@NP	axons	20413
@NP	the contusion injury	20428
@NP	All numbers	20450
@NP	FB-labeled neurons	20465
@NP	motor cortex and brainstem nuclei	20497
@NP	red nucleus	20541
@NP	lateral vestibular nucleus	20554
@NP	reticular formation	20582
@NP	raphe nucleus	20603
@NP	locus coeruleus	20622
@NP	Table 1	20653
@NP	Fig. 8	20674
@NP	the total number of labeled neurons	20694
@NP	the total number	20694
@NP	labeled neurons	20714
@NP	3 weeks -LRB- SCI 3w , n = 3 -RRB-	20761
@NP	SCI 3w , n = 3	20770
@NP	SCI 3w	20770
@NP	n = 3	20778
@NP	n	20778
@NP	3	20780
@NP	22 weeks -LRB- SCI 22w , i.e. , Group 1 : SCI Control , n = 4 -RRB-	20787
@NP	SCI 22w , i.e. , Group 1 : SCI Control , n = 4	20797
@NP	SCI 22w , i.e.	20797
@NP	SCI 22w	20797
@NP	i.e.	20806
@NP	Group 1 : SCI Control	20812
@NP	Group 1	20812
@NP	SCI Control	20821
@NP	n = 4	20834
@NP	n	20834
@NP	4	20836
@NP	SCI	20845
@NP	Rats from either Group 2 -LRB- SCI+TANES , n = 4 -RRB-	20850
@NP	Rats	20850
@NP	Group 2	20867
@NP	SCI+TANES , n = 4	20876
@NP	SCI+TANES	20876
@NP	n = 4	20887
@NP	n	20887
@NP	4	20889
@NP	Group 3 -LRB- SCI+BT , n = 4 -RRB-	20895
@NP	Group 3	20895
@NP	SCI+BT , n = 4	20904
@NP	SCI+BT	20904
@NP	n = 4	20912
@NP	n	20912
@NP	4	20914
@NP	slight changes in the number of labeled neurons	20922
@NP	slight changes	20922
@NP	the number of labeled neurons	20940
@NP	the number	20940
@NP	labeled neurons	20954
@NP	that from Group 1	20989
@NP	that	20989
@NP	Group 1	20999
@NP	SCI 22w	21008
@NP	the difference	21022
@NP	rats from Group 4 -LRB- SCI+BT + TANES , n = 5 -RRB-	21080
@NP	rats from Group 4	21080
@NP	rats	21080
@NP	Group 4	21090
@NP	SCI+BT + TANES	21099
@NP	SCI+BT	21099
@NP	TANES	21107
@NP	n = 5	21114
@NP	n	21114
@NP	= 5	21115
@NP	a significant increase in the number of labeled neurons	21124
@NP	a significant increase	21124
@NP	the number of labeled neurons	21150
@NP	the number	21150
@NP	labeled neurons	21164
@NP	the difference between Group 4 and any other group	21185
@NP	the difference	21185
@NP	Group 4 and any other group	21208
@NP	Group 4	21208
@NP	any other group	21220
@NP	p < 0.05	21266
@NP	p	21266
@NP	< 0.05	21267
@NP	<	21267
@NP	0.05	21268
@NP	addition	21278
@NP	FBlabeled neurons in Group 4	21288
@NP	FBlabeled neurons	21288
@NP	Group 4	21309
@NP	that of control group	21347
@NP	that	21347
@NP	control group	21355
@NP	most of nuclei	21372
@NP	most	21372
@NP	nuclei	21380
@NP	motor cortex and locus coeruleus	21399
@NP	motor cortex	21399
@NP	locus coeruleus	21416
@NP	the cortex	21437
@NP	the difference	21449
@NP	Group 1 -LRB- SCI 22w -RRB- and Group 4 -LRB- SCI+BT+TANES -RRB-	21472
@NP	Group 1	21472
@NP	SCI 22w	21481
@NP	Group 4	21494
@NP	SCI+BT+TANES	21503
@NP	rats in Group 4	21545
@NP	rats	21545
@NP	Group 4	21553
@NP	10 times more labeled neurons than that in Group 1	21566
@NP	10 times more	21566
@NP	neurons	21588
@NP	that in Group 1	21601
@NP	that	21601
@NP	Group 1	21609
@NP	2.5	21618
@NP	Positive correlation between FB-labeled neurons and BBB scores	21623
@NP	Positive correlation	21623
@NP	FB-labeled neurons and BBB scores	21652
@NP	FB-labeled neurons	21652
@NP	BBB scores	21675
@NP	a potential relationship between BBB scores	21705
@NP	a potential relationship	21705
@NP	BBB scores	21738
@NP	regenerated axons	21753
@NP	the cortex and nuclei of brainstem , numbers of FB-labeled neurons	21776
@NP	the cortex and nuclei	21776
@NP	brainstem , numbers of FB-labeled neurons	21801
@NP	brainstem	21801
@NP	numbers of FB-labeled neurons	21812
@NP	numbers	21812
@NP	FB-labeled neurons	21823
@NP	all 23 cases with FB tracing	21847
@NP	all 23 cases	21847
@NP	FB tracing	21865
@NP	FB	21865
@NP	the BBB open field locomotor scores	21897
@NP	Linear regression analysis	21934
@NP	a significant positive correlation between FB-labeled neurons	21968
@NP	a significant positive correlation	21968
@NP	FB-labeled neurons	22011
@NP	BBB scores -LRB- r = 0.89 , p < 0.001 ; Fig. 9 -RRB-	22034
@NP	BBB scores -LRB- r = 0.89 ,	22034
@NP	BBB scores	22034
@NP	r = 0.89	22046
@NP	r	22046
@NP	p	22054
@NP	0.001 ; Fig. 9	22056
@NP	0.001	22056
@NP	Fig. 9	22063
@NP	Discussion Here	22076
@NP	Discussion	22076
@NP	we	22092
@NP	significant recovery of locomotor function	22107
@NP	significant recovery	22107
@NP	locomotor function	22131
@NP	ratswith chronic spinal cord contusion injury	22168
@NP	the application of TANES	22217
@NP	the application	22217
@NP	TANES	22236
@NP	combinedwith scar ablation and LP	22243
@NP	combinedwith scar	22243
@NP	ablation and LP	22261
@NP	OEC transplantation into the injury site	22278
@NP	OEC transplantation	22278
@NP	the injury site	22303
@NP	Our results	22320
@NP	the temporary , active ability of walking induced by TANES	22350
@NP	the temporary , active ability	22350
@NP	TANES	22402
@NP	permanent ability to walk , namely functional recovery	22432
@NP	permanent ability to walk	22432
@NP	functional recovery	22466
@NP	The improvement of neurological outcome	22487
@NP	The improvement	22487
@NP	neurological outcome	22506
@NP	the spinal plasticity based on the tissue repair and axonal regeneration	22550
@NP	the spinal plasticity	22550
@NP	the tissue repair and axonal regeneration	22581
@NP	the tissue repair	22581
@NP	axonal regeneration	22603
@NP	We	22624
@NP	the activitydependent plasticity	22640
@NP	the activation of the CPG	22692
@NP	the activation	22692
@NP	the CPG	22710
@NP	the TANES	22723
@NP	the activation of the CPG	22756
@NP	the activation	22756
@NP	the CPG	22774
@NP	the lesion level of the spinal cord	22788
@NP	the lesion level	22788
@NP	the spinal cord	22808
@NP	It	22825
@NP	many treatment approaches including cell transplantation	22847
@NP	many treatment approaches	22847
@NP	cell transplantation	22883
@NP	functional recovery in acute or sub-acute SCImodels	22946
@NP	functional recovery	22946
@NP	acute or sub-acute SCImodels	22969
@NP	the same or similar approaches	22999
@NP	chronic models	23073
@NP	Azanchi et al. , 2004 ; Houle and Tessler , 2003 ; Tetzlaff et al. , 2011	23089
@NP	Azanchi	23089
@NP	et al. , 2004 ; Houle and Tessler , 2003 ; Tetzlaff et al. , 2011	23097
@NP	et al. , 2004	23097
@NP	et al.	23097
@NP	2004	23105
@NP	Houle and Tessler , 2003	23111
@NP	Houle and Tessler	23111
@NP	2003	23130
@NP	Tetzlaff et al. , 2011	23136
@NP	Tetzlaff	23136
@NP	et al. , 2011	23145
@NP	et al.	23145
@NP	2011	23153
@NP	our results from this study	23170
@NP	our results	23170
@NP	this study	23187
@NP	the average BBB scores	23223
@NP	only about 2 points	23252
@NP	9.33 to 11.46	23278
@NP	the rats receiving full treatments	23297
@NP	the rats	23297
@NP	full treatments	23316
@NP	fact	23336
@NP	it	23341
@NP	a remarkable recovery of locomotor function	23347
@NP	a remarkable recovery	23347
@NP	locomotor function	23372
@NP	The average BBB score	23392
@NP	9.33 means	23417
@NP	most of rats -LRB- 7/12 -RRB-	23433
@NP	most	23433
@NP	rats -LRB- 7/12 -RRB-	23441
@NP	rats	23441
@NP	7/12	23447
@NP	their body weight	23471
@NP	the	23496
@NP	phases	23521
@NP	treatment	23535
@NP	combination treatments	23552
@NP	most of them -LRB- 9/12 -RRB-	23585
@NP	most of them	23585
@NP	most	23585
@NP	them	23593
@NP	9/12	23599
@NP	body-weight support	23670
@NP	some of them -LRB- 5/12 -RRB-	23695
@NP	some of them	23695
@NP	some	23695
@NP	them	23703
@NP	5/12	23709
@NP	occasional or frequent coordination of front limbs and hind limbs	23727
@NP	occasional or frequent coordination	23727
@NP	front limbs and hind limbs	23766
@NP	front limbs	23766
@NP	hind limbs	23782
@NP	Fig. 3	23810
@NP	the course of functional recovery of a representative case	23823
@NP	the course	23823
@NP	functional recovery of a representative case	23837
@NP	functional recovery	23837
@NP	a representative case	23860
@NP	the kinematic analysis of hind limb stepping cycle	23883
@NP	the kinematic analysis	23883
@NP	hind limb stepping cycle	23909
@NP	hind limb	23909
@NP	cycle	23928
@NP	the assessment in a certain degree	23948
@NP	the assessment	23948
@NP	a certain degree	23966
@NP	a critical progress	23995
@NP	ratswith chronic spinal injury in neurology	24019
@NP	ratswith chronic spinal injury	24019
@NP	neurology	24053
@NP	recent years	24067
@NP	spinal plasticity	24081
@NP	the physical activity	24113
@NP	a major contributor	24150
@NP	functional recovery	24173
@NP	Behrman and Harkema	24194
@NP	Behrman	24194
@NP	Harkema	24206
@NP	2007 ; Chen et al. , 2007 ; Dunlop , 2008 ; Jayaraman et al. , 2006	24215
@NP	2007	24215
@NP	Chen et al. , 2007 ; Dunlop , 2008 ; Jayaraman et al. , 2006	24221
@NP	Chen	24221
@NP	et al. , 2007 ; Dunlop , 2008 ; Jayaraman et al. , 2006	24226
@NP	et al. , 2007	24226
@NP	et al.	24226
@NP	2007	24234
@NP	Dunlop , 2008	24240
@NP	Dunlop	24240
@NP	2008	24248
@NP	Jayaraman et al. , 2006	24254
@NP	Jayaraman	24254
@NP	et al. , 2006	24264
@NP	et al.	24264
@NP	2006	24272
@NP	This	24279
@NP	the neurons '	24294
@NP	their anatomical and functional connectivity in response	24328
@NP	their anatomical and functional connectivity	24328
@NP	response	24376
@NP	environmental input	24388
@NP	The resulting effect	24409
@NP	a new or modified output	24433
@NP	recovering behaviors -LRB- Dunlop , 2008 -RRB-	24474
@NP	recovering behaviors	24474
@NP	Dunlop	24496
@NP	2008	24504
@NP	the mechanisms	24520
@NP	the locomotor recovery	24545
@NP	intense repetitive training and locomotor training	24579
@NP	activity-dependent plasticity likely	24656
@NP	activity-dependent plasticity	24656
@NP	a major role -LRB- Lynskey et al. , 2008 -RRB-	24699
@NP	a major role	24699
@NP	Lynskey	24713
@NP	et al. , 2008	24721
@NP	et al.	24721
@NP	2008	24729
@NP	Studies	24736
@NP	activity-dependent plasticity	24762
@NP	physical therapy benefits	24804
@NP	the functional recovery	24830
@NP	various models	24857
@NP	Becker	24873
@NP	et al. , 2003 ; Sadowsky and McDonald , 2009 ; Thickbroom and Mastaglia , 2009	24880
@NP	et al. , 2003	24880
@NP	et al.	24880
@NP	2003	24888
@NP	Sadowsky and McDonald , 2009	24894
@NP	Sadowsky and McDonald	24894
@NP	2009	24917
@NP	Thickbroom and Mastaglia , 2009	24923
@NP	Thickbroom and Mastaglia	24923
@NP	2009	24949
@NP	many strategies to restore locomotion after thoracic SCI	24967
@NP	locomotion	24994
@NP	thoracic SCI	25011
@NP	approaches	25040
@NP	the lumbar neuronal network -LRB- CPG -RRB-	25073
@NP	the lumbar neuronal network	25073
@NP	CPG	25102
@NP	its plasticity -LRB- Boulenguez and Vinay , 2009 -RRB-	25111
@NP	its plasticity	25111
@NP	Boulenguez and Vinay , 2009	25127
@NP	Boulenguez	25127
@NP	Vinay , 2009	25142
@NP	Vinay	25142
@NP	2009	25149
@NP	The CPG	25156
@NP	patterns of rhythmic activity for locomotion	25184
@NP	patterns	25184
@NP	rhythmic activity for locomotion	25196
@NP	rhythmic activity	25196
@NP	locomotion	25218
@NP	the absence	25237
@NP	external feedback or supraspinal control	25252
@NP	Deliagina	25294
@NP	et al. , 1999 ; Grillner , 1985	25304
@NP	et al.	25304
@NP	1999 ; Grillner	25312
@NP	1999	25312
@NP	Grillner	25318
@NP	1985	25328
@NP	our rat model	25338
@NP	the CPG located in L1-2 -LRB- Magnuson et al. , 1999 , 2005 -RRB-	25353
@NP	the CPG	25353
@NP	L1-2 -LRB- Magnuson et al. , 1999 , 2005 -RRB-	25372
@NP	L1-2	25372
@NP	Magnuson	25378
@NP	et al. , 1999 , 2005	25387
@NP	et al.	25387
@NP	1999	25395
@NP	2005	25401
@NP	contusion injury in T10	25431
@NP	contusion injury	25431
@NP	T10	25451
@NP	the TANES stimulation	25463
@NP	active body	25485
@NP	hind limbs	25525
@NP	right alternation	25546
@NP	This temporary , technique-induced walking ability	25572
@NP	the result	25643
@NP	the activation of CPG , triggered by TANES -LRB- Zhang et al. , 2010 -RRB-	25659
@NP	the activation	25659
@NP	CPG	25677
@NP	TANES -LRB- Zhang et al. , 2010 -RRB-	25695
@NP	TANES	25695
@NP	Zhang	25702
@NP	et al. , 2010	25708
@NP	et al.	25708
@NP	2010	25716
@NP	the present study	25726
@NP	significant functional recovery	25745
@NP	chronic SCI	25782
@NP	the application of TANES	25804
@NP	the application	25804
@NP	TANES	25823
@NP	all likelihood	25836
@NP	the activity-dependent plasticity	25868
@NP	the injury level promoted by TANES through the activation of CPG	25908
@NP	the injury level	25908
@NP	TANES	25937
@NP	the activation of CPG	25951
@NP	the activation	25951
@NP	CPG	25969
@NP	This	25974
@NP	the transformation of temporary , active ability	25991
@NP	the transformation	25991
@NP	temporary , active ability	26013
@NP	TANES	26058
@NP	permanent ability to walk , namely functional recovery	26069
@NP	permanent ability to walk	26069
@NP	functional recovery	26103
@NP	it	26128
@NP	Consistent with our previous studies , observation from this study	26165
@NP	Consistent	26165
@NP	our previous studies , observation from this study	26181
@NP	our previous studies	26181
@NP	observation from this study	26203
@NP	observation	26203
@NP	this study	26220
@NP	the basic treatments including scar ablation and LP/OEC transplantation	26258
@NP	the basic treatments	26258
@NP	scar ablation and LP/OEC transplantation	26289
@NP	scar ablation	26289
@NP	LP/OEC transplantation	26307
@NP	tissue repair	26338
@NP	axonal regeneration	26356
@NP	NF staining and P0-positive myelination	26389
@NP	NF staining	26389
@NP	P0-positive myelination	26405
@NP	only substantial tissue repair and profound axonal regeneration	26440
@NP	only substantial tissue repair	26440
@NP	profound axonal regeneration	26475
@NP	functional recovery	26533
@NP	chronic SCI models -LRB- Zhang et al. , 2011a -RRB-	26570
@NP	chronic SCI models	26570
@NP	Zhang	26590
@NP	et al. , 2011a	26596
@NP	et al.	26596
@NP	2011a	26604
@NP	The fast blue tracing data	26612
@NP	The fast blue	26612
@NP	data	26634
@NP	TANES	26657
@NP	supraspinal axonal regeneration	26675
@NP	the brain and brainstem , which may be related with the functional recovery	26710
@NP	the brain and brainstem	26710
@NP	the functional recovery	26761
@NP	It	26786
@NP	the TANES	26809
@NP	the CPG	26829
@NP	signals	26847
@NP	the brain and brainstem	26861
@NP	fibers -LRB- Giuliani and Smith , 1987 -RRB-	26914
@NP	fibers	26914
@NP	Giuliani and Smith	26922
@NP	1987	26942
@NP	rise	26960
@NP	a strikingly extended activation	26968
@NP	cortex and brainstem -LRB- Spenger et al. , 2000 -RRB-	27004
@NP	cortex and brainstem	27004
@NP	Spenger	27026
@NP	et al. , 2000	27034
@NP	et al.	27034
@NP	2000	27042
@NP	supraspinal axon regeneration	27062
@NP	incomplete spinal cord injury	27096
@NP	the implementation of brain motor control	27127
@NP	the implementation	27127
@NP	brain motor control	27149
@NP	the profile	27180
@NP	residual brain descending input	27195
@NP	its integration	27231
@NP	the functional neuronal circuits	27252
@NP	the lesion -LRB- Dimitrijevic et al. , 2005 -RRB-	27291
@NP	the lesion	27291
@NP	Dimitrijevic	27303
@NP	et al. , 2005	27316
@NP	et al.	27316
@NP	2005	27324
@NP	These re-growing descending fibers	27331
@NP	the motor cortex and brainstem nuclei associated with hind limb locomotion	27390
@NP	the motor cortex	27390
@NP	brainstem nuclei associated with hind limb locomotion	27411
@NP	brainstem nuclei	27411
@NP	hind limb locomotion	27444
@NP	the establishment	27478
@NP	a new structural relationship between the brain and spinal cord	27499
@NP	a new structural relationship	27499
@NP	the brain and spinal cord	27537
@NP	the brain	27537
@NP	spinal cord	27551
@NP	The functions of this new structural relationship	27564
@NP	The functions	27564
@NP	this new structural relationship	27581
@NP	an alternative , but characteristic and consistent neurocontrol	27631
@NP	Dimitrijevic , 1994 ; Dimitrijevic et al. , 1983 , 2005	27695
@NP	Dimitrijevic	27695
@NP	1994 ; Dimitrijevic et al. , 1983	27709
@NP	1994	27709
@NP	Dimitrijevic et al. , 1983	27715
@NP	Dimitrijevic	27715
@NP	et al. , 1983	27728
@NP	et al.	27728
@NP	1983	27736
@NP	2005	27742
@NP	this study	27752
@NP	the differences in BBB scores between the groups	27763
@NP	the differences	27763
@NP	BBB scores between the groups	27782
@NP	BBB scores	27782
@NP	the groups	27801
@NP	the activity-dependent plasticity	27841
@NP	the level of injury site	27881
@NP	the level	27881
@NP	injury site	27894
@NP	Rats in injury	27907
@NP	Rats	27907
@NP	injury	27915
@NP	group -LRB- SCI Control -RRB-	27928
@NP	group	27928
@NP	SCI Control	27935
@NP	almost no change	27955
@NP	their BBB scores	27975
@NP	the last 16 weeks	27999
@NP	observation	28020
@NP	intervention treatment	28069
@NP	endogenous , spontaneous repair processes	28093
@NP	SCI	28168
@NP	Beattie	28173
@NP	et al. , 1997	28181
@NP	et al.	28181
@NP	1997	28189
@NP	Belegu et al. , 2007	28195
@NP	Belegu	28195
@NP	et al. , 2007	28202
@NP	et al.	28202
@NP	2007	28210
@NP	Brook et al. , 2000	28216
@NP	Brook	28216
@NP	et al. , 2000	28222
@NP	et al.	28222
@NP	2000	28230
@NP	Zhang et al. , 2011a	28236
@NP	Zhang	28236
@NP	et al. , 2011a	28242
@NP	et al.	28242
@NP	2011a	28250
@NP	Rats	28258
@NP	scar ablation and LP/OEC transplantation -LRB- SCI+BT -RRB-	28277
@NP	scar ablation and LP/OEC transplantation	28277
@NP	SCI+BT	28319
@NP	their BBB scores	28345
@NP	they	28393
@NP	significant tissue repair and an increase	28405
@NP	significant tissue repair	28405
@NP	an increase	28435
@NP	the number of P0-positive myelination	28450
@NP	the number	28450
@NP	P0-positive myelination	28464
@NP	This observation	28489
@NP	This	28489
@NP	observation	28494
@NP	our previous results	28525
@NP	others ' study -LRB- Steward et al. , 2006 -RRB-	28550
@NP	others ' study	28550
@NP	others '	28550
@NP	Steward	28565
@NP	et al. , 2006	28573
@NP	et al.	28573
@NP	2006	28581
@NP	andmay share the same mechanism	28588
@NP	andmay share	28588
@NP	the same mechanism	28601
@NP	effective activity-dependent plasticity induced by locomotor training	28635
@NP	effective activity-dependent plasticity	28635
@NP	locomotor training	28686
@NP	cellular transplantation therapies	28722
@NP	improvement of motor function	28792
@NP	improvement	28792
@NP	motor function	28807
@NP	rats with chronic SCI	28825
@NP	rats	28825
@NP	chronic SCI	28835
@NP	the injured rats with both basic treatments and TANES -LRB- SCI+BT + TANES -RRB-	28857
@NP	the injured rats with both basic treatments and TANES	28857
@NP	the injured rats	28857
@NP	both basic treatments and TANES	28879
@NP	SCI+BT + TANES	28912
@NP	SCI+BT	28912
@NP	TANES	28920
@NP	their BBB scores	28932
@NP	increasing and improvement of functional recovery	28963
@NP	increasing and improvement	28963
@NP	functional recovery	28993
@NP	this	29034
@NP	the activity-dependent plasticity	29060
@NP	TANES	29106
@NP	the activation of CPG -LRB- Zhang et al. , 2010 -RRB-	29120
@NP	the activation	29120
@NP	CPG -LRB- Zhang et al. , 2010 -RRB-	29138
@NP	CPG	29138
@NP	Zhang	29143
@NP	et al. , 2010	29149
@NP	et al.	29149
@NP	2010	29157
@NP	rats that received only TANES but no basic treatments -LRB- SCI+TANES -RRB-	29179
@NP	rats	29179
@NP	only TANES but no basic treatments -LRB- SCI+TANES -RRB-	29198
@NP	only TANES	29198
@NP	no basic treatments -LRB- SCI+TANES -RRB-	29213
@NP	no basic treatments	29213
@NP	SCI+TANES	29234
@NP	an obvious increase in their BBB scores	29254
@NP	an obvious increase	29254
@NP	their BBB scores	29277
@NP	their tissue repair , P0-positivemyelination and FB tracing	29304
@NP	their tissue repair	29304
@NP	P0-positivemyelination and FB tracing	29325
@NP	P0-positivemyelination and FB	29325
@NP	the control animals	29400
@NP	The functional improvement in this conditionmay	29421
@NP	The functional improvement	29421
@NP	this conditionmay	29451
@NP	the activity-dependent plasticity	29483
@NP	TANES	29528
@NP	this intrinsic plasticity	29543
@NP	allowfunctional recovery	29573
@NP	the absence	29601
@NP	significant regeneration	29616
@NP	Edgerton	29642
@NP	et al. , 2004 ; Harel and Strittmatter , 2006	29651
@NP	et al.	29651
@NP	2004 ; Harel and Strittmatter	29659
@NP	2004	29659
@NP	Harel and Strittmatter	29665
@NP	2006	29689
@NP	steady tissue repair or axonal regeneration as an anatomic foundation	29718
@NP	steady tissue repair or axonal regeneration	29718
@NP	an anatomic foundation	29765
@NP	the role of physical therapy	29789
@NP	the role	29789
@NP	physical therapy	29801
@NP	functional recovery	29849
@NP	rats with chronic SCI	29872
@NP	rats	29872
@NP	chronic SCI	29882
@NP	This inference	29895
@NP	some cases in a recent clinical trial -LRB- Schalow , 2008 -RRB-	29929
@NP	some cases	29929
@NP	a recent clinical trial -LRB- Schalow , 2008 -RRB-	29943
@NP	a recent clinical trial	29943
@NP	Schalow	29968
@NP	2008	29977
@NP	summary	29987
@NP	TANES	29996
@NP	functional recovery in rats with chronically contused spinal cord	30025
@NP	functional recovery	30025
@NP	rats with chronically contused spinal cord	30048
@NP	rats	30048
@NP	chronically contused spinal cord	30058
@NP	scar ablation and LP/OEC transplantation	30097
@NP	the activity-dependent plasticity	30162
@NP	the injury level promoted by the activation of CPG	30202
@NP	the injury level	30202
@NP	the activation of CPG	30231
@NP	the activation	30231
@NP	CPG	30249
@NP	moderate functional recovery	30263
@NP	the TANES in the absence of steady tissue repair and axonal regeneration	30311
@NP	the TANES	30311
@NP	the absence of steady tissue repair and axonal regeneration	30324
@NP	the absence	30324
@NP	steady tissue repair and axonal regeneration	30339
@NP	steady tissue repair	30339
@NP	axonal regeneration	30364
@NP	tissue repair and axonal regeneration	30385
@NP	tissue repair	30385
@NP	axonal regeneration	30403
@NP	the anatomical foundation	30441
@NP	effective plasticity , which renders the injured rat permanent ability to walk	30470
@NP	effective plasticity	30470
@NP	the injured rat permanent ability	30506
@NP	TANES	30549
@NP	axonal regeneration	30564
@NP	the cortex and brainstem	30587
@NP	the improvement of motor behavior	30639
@NP	the improvement	30639
@NP	motor behavior	30658
@NP	Our results	30674
@NP	light	30697
@NP	the study of chronic SCI	30706
@NP	the study	30706
@NP	chronic SCI	30719
@NP	TANES	30732
@NP	considerable potential	30747
@NP	improvement	30784
@NP	functional outcomes in patients with chronic SCI	30799
@NP	functional outcomes	30799
@NP	patients with chronic SCI	30822
@NP	patients	30822
@NP	chronic SCI	30836
@NP	Experimental procedures 4.1 .	30853
@NP	Experimental procedures	30853
@NP	4.1	30877
@NP	Animal and grouping Long	30882
@NP	Animal	30882
@NP	grouping Long	30893
@NP	Evans rats -LRB- female , body weight 200 -- 220 g -RRB-	30907
@NP	Evans rats	30907
@NP	female , body weight 200 -- 220 g	30919
@NP	female	30919
@NP	body weight 200 -- 220 g	30927
@NP	body weight 200	30927
@NP	body weight	30927
@NP	200	30939
@NP	220 g	30943
@NP	this study	30964
@NP	The rats	30976
@NP	plastic cages	31007
@NP	standard conditions with free access	31027
@NP	standard conditions	31027
@NP	free access	31052
@NP	drinking water and standard food	31067
@NP	drinking water	31067
@NP	standard food	31086
@NP	All rats	31101
@NP	contusion injury	31119
@NP	4 groups	31167
@NP	Rats in Group 1 -LRB- SCI Control , n = 12 -RRB-	31177
@NP	Rats in Group 1	31177
@NP	Rats	31177
@NP	Group 1	31185
@NP	SCI Control , n = 12	31194
@NP	SCI Control	31194
@NP	n = 12	31207
@NP	n	31207
@NP	12	31209
@NP	the injury	31227
@NP	alone control in order	31238
@NP	alone control	31238
@NP	order	31255
@NP	a baseline of the locomotor behavior	31268
@NP	a baseline	31268
@NP	the locomotor behavior	31282
@NP	Rats in Group 2 -LRB- SCI+TANES , n = 9 -RRB-	31306
@NP	Rats in Group 2	31306
@NP	Rats	31306
@NP	Group 2	31314
@NP	SCI+TANES , n = 9	31323
@NP	SCI+TANES	31323
@NP	n = 9	31334
@NP	n	31334
@NP	9	31336
@NP	TANES starting at 7 weeks after contusion injury until 22 weeks	31348
@NP	TANES	31348
@NP	7 weeks	31366
@NP	contusion injury	31380
@NP	22 weeks	31403
@NP	Rats in Group 3 -LRB- SCI+BT , n = 10 -RRB-	31413
@NP	Rats in Group 3	31413
@NP	Rats	31413
@NP	Group 3	31421
@NP	SCI+BT , n = 10	31430
@NP	SCI+BT	31430
@NP	n = 10	31438
@NP	n	31438
@NP	10	31440
@NP	basic treatments -LRB- BT -RRB- 6 weeks	31453
@NP	basic treatments -LRB- BT -RRB-	31453
@NP	basic treatments	31453
@NP	BT	31471
@NP	6 weeks	31475
@NP	contusion injury	31489
@NP	the basic treatments	31507
@NP	scar ablation and LP/OEC transplantation as in our previous study	31536
@NP	scar ablation and LP/OEC transplantation	31536
@NP	our previous study	31583
@NP	Rats in Group 4 -LRB- SCI+BT+TANES , n = 12 -RRB-	31603
@NP	Rats in Group 4	31603
@NP	Rats	31603
@NP	Group 4	31611
@NP	SCI+BT+TANES , n = 12	31620
@NP	SCI+BT+TANES	31620
@NP	n = 12	31634
@NP	n	31634
@NP	12	31636
@NP	basic treatments	31649
@NP	TANES	31678
@NP	Twenty two weeks	31685
@NP	contusion injury or 16 weeks after transplantation	31708
@NP	contusion injury	31708
@NP	16 weeks after transplantation	31728
@NP	16 weeks	31728
@NP	transplantation	31743
@NP	all rats	31760
@NP	sodium pentobarbital -LRB- 60mg/kg , i.p. -RRB-	31799
@NP	sodium pentobarbital	31799
@NP	60mg/kg , i.p.	31821
@NP	60mg/kg	31821
@NP	phosphate-buffered 4 % paraformaldehyde	31869
@NP	the neurons	31918
@NP	the cortex and brainstem	31933
@NP	axons	31965
@NP	the contusion	31980
@NP	the injury site	32016
@NP	4 to 5 rats from each group	32033
@NP	4 to 5 rats	32033
@NP	each group	32050
@NP	fast blue	32099
@NP	the end of the experiment	32112
@NP	the end	32112
@NP	the experiment	32123
@NP	addition	32142
@NP	3 additional ratswere	32152
@NP	the same purpose as subacute injury control	32183
@NP	the same purpose	32183
@NP	subacute injury control	32203
@NP	SCI 3w ; 3 weeks	32228
@NP	SCI 3w	32228
@NP	3 weeks	32236
@NP	contusion	32250
@NP	All rats with neurotracing	32262
@NP	All rats	32262
@NP	neurotracing	32276
@NP	one more	32317
@NP	week	32326
@NP	All surgical and physical therapy procedures	32332
@NP	interventions , pre - and post-surgery care and electrical stimulation	32388
@NP	interventions	32388
@NP	pre - and post-surgery care and electrical stimulation	32403
@NP	pre - and post-surgery care	32403
@NP	electrical stimulation	32434
@NP	the Institutional Animal Use and Care Committee of CARE Research , Inc	32475
@NP	the Institutional Animal Use and Care Committee	32475
@NP	CARE Research , Inc	32526
@NP	CARE Research	32526
@NP	Inc	32541
@NP	the Guide for the Care and Use of Laboratory Animals -LRB- 1996 -RRB-	32569
@NP	the Guide for the Care and Use of Laboratory Animals	32569
@NP	the Care	32583
@NP	Laboratory	32603
@NP	1996	32623
@NP	4.2	32630
@NP	Preparation of LP and OECs for transplantation LP used for transplantation	32635
@NP	Preparation	32635
@NP	LP and OECs	32650
@NP	transplantation LP used for transplantation	32666
@NP	transplantation LP	32666
@NP	transplantation	32694
@NP	the protocol as described previously -LRB- Zhang et al. , 2011a -RRB-	32733
@NP	the protocol	32733
@NP	Zhang	32771
@NP	et al. , 2011a	32777
@NP	et al.	32777
@NP	2011a	32785
@NP	the olfactory mucosa	32802
@NP	the nasal septum of a donor Long -- Evans rat	32841
@NP	the nasal septum	32841
@NP	a donor Long -- Evans rat	32861
@NP	Evans	32874
@NP	Dispase II -LRB- Roche -RRB- for 35 -- 40 min at 37 °C	32902
@NP	Dispase II -LRB- Roche -RRB- for 35	32902
@NP	Dispase II -LRB- Roche -RRB-	32902
@NP	Dispase II	32902
@NP	Roche	32914
@NP	35	32925
@NP	40 min at 37 °C	32928
@NP	40 min	32928
@NP	37 °C	32938
@NP	The olfactory epithelium	32945
@NP	forceps thereby exposing the LP	33000
@NP	forceps	33000
@NP	the LP	33025
@NP	transplantation	33037
@NP	the LP	33054
@NP	1.0 × 1.0 mm squares	33074
@NP	L-15 on ice	33104
@NP	L-15	33104
@NP	ice	33112
@NP	transplant	33122
@NP	OECs	33134
@NP	the LP of adult Long	33158
@NP	the LP	33158
@NP	adult Long	33168
@NP	Evans rats according to the basic protocols	33179
@NP	Evans rats	33179
@NP	the basic protocols	33203
@NP	elsewhere -LRB- Au and Roskams , 2002 -RRB-	33232
@NP	elsewhere	33232
@NP	Au and Roskams	33243
@NP	2002	33259
@NP	isolated LP	33275
@NP	37 °C in collagenase	33303
@NP	37 °C	33303
@NP	collagenase	33312
@NP	30 min	33328
@NP	incubation	33347
@NP	SD -LRB- Soybean Trypsin inhibitor/DNase -RRB- solution for 15 min	33361
@NP	SD -LRB- Soybean Trypsin inhibitor/DNase -RRB- solution	33361
@NP	SD -LRB- Soybean Trypsin inhibitor/DNase -RRB-	33361
@NP	SD	33361
@NP	Soybean Trypsin inhibitor/DNase	33365
@NP	15 min	33411
@NP	The tissue	33419
@NP	3 times	33459
@NP	22	33475
@NP	25 gauge	33482
@NP	growth medium	33504
@NP	400 × g	33527
@NP	growth	33548
@NP	medium on a matrigel-coated T25 flask	33555
@NP	medium	33555
@NP	a matrigel-coated T25 flask	33565
@NP	24 h	33612
@NP	non-adherent cells	33618
@NP	fresh media	33654
@NP	the culture	33682
@NP	Cultures	33695
@NP	an additional 4	33719
@NP	7 days until nearly confluent	33735
@NP	7 days	33735
@NP	contaminating fibroblasts	33781
@NP	the cultures -LRB- Noble and Murray , 1984 -RRB-	33812
@NP	the cultures	33812
@NP	Noble and Murray	33826
@NP	1984	33844
@NP	OECs -LRB- among which may contain some contaminated Schwann cells -RRB-	33851
@NP	OECs	33851
@NP	some contaminated Schwann cells	33881
@NP	some	33881
@NP	Schwann cells	33899
@NP	liquid nitrogen in working aliquots	33943
@NP	liquid nitrogen	33943
@NP	working aliquots	33962
@NP	4.3	33980
@NP	Spinal cord injury and post-op care Contusion injury to the spinal cord	33985
@NP	Spinal cord injury	33985
@NP	post-op care Contusion injury to the spinal cord	34008
@NP	post-op care Contusion injury	34008
@NP	the spinal cord	34041
@NP	the NYU -LRB- New York University -RRB- impactor device	34079
@NP	New York University	34088
@NP	Zhang et al. , 2000	34147
@NP	Zhang	34147
@NP	et al.	34153
@NP	2000	34161
@NP	deep anesthesia with sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	34182
@NP	deep anesthesia	34182
@NP	sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	34203
@NP	sodium pentobarbital	34203
@NP	50 mg/kg , i.p.	34225
@NP	50 mg/kg	34225
@NP	the vertebral column	34242
@NP	the spinous process	34295
@NP	vertebra	34318
@NP	thoracic -LRB- T -RRB- level T7 and T10	34327
@NP	thoracic -LRB- T -RRB-	34327
@NP	level T7 and T10	34340
@NP	a dorsal laminectomy	34364
@NP	T8 and T9	34402
@NP	the spinal cord segments T9 and T10	34413
@NP	the dura mater intact	34467
@NP	the dura mater	34467
@NP	The 10 g impact rod	34490
@NP	spinal cord segment T10	34530
@NP	a height of 25 mm	34559
@NP	a height	34559
@NP	25 mm	34571
@NP	the exposed part of the cord	34578
@NP	the exposed part	34578
@NP	the cord	34598
@NP	a piece of adipose tissue	34624
@NP	a piece	34624
@NP	adipose tissue	34635
@NP	The contusion injury	34651
@NP	hind limb	34684
@NP	locomotor deficits as described previously	34694
@NP	locomotor deficits	34694
@NP	Constantini and Young	34738
@NP	1994	34761
@NP	Analgesia buprenorphine -LRB- 0.02 mg/kg , sc , b.i.d. -RRB-	34768
@NP	Analgesia buprenorphine	34768
@NP	0.02 mg/kg , sc , b.i.d.	34793
@NP	0.02 mg/kg	34793
@NP	sc	34804
@NP	b.i.d.	34808
@NP	the pain for the first two days	34839
@NP	the pain	34839
@NP	the first two days	34852
@NP	injury/surgery	34877
@NP	Antibiotic cephazolin -LRB- 20mg/kg , sc , b.i.d. -RRB-	34893
@NP	Antibiotic cephazolin	34893
@NP	20mg/kg , sc , b.i.d.	34916
@NP	possible infection	34965
@NP	the wound and bladder for one	34987
@NP	the wound and bladder	34987
@NP	one	35013
@NP	week	35017
@NP	Urinary bladders	35023
@NP	hand	35066
@NP	twice a day	35071
@NP	adequate spontaneous voiding returned	35089
@NP	adequate spontaneous voiding	35089
@NP	attention	35128
@NP	the body skin	35155
@NP	addition	35177
@NP	saline solution -LRB- 0.9 % , 10 ml , sc -RRB-	35187
@NP	saline solution	35187
@NP	0.9 %	35204
@NP	10 ml	35210
@NP	sc	35217
@NP	one	35240
@NP	week	35244
@NP	dehydration	35260
@NP	The body weight of animals	35273
@NP	The body weight	35273
@NP	animals	35292
@NP	the first two weeks	35325
@NP	surgery and once a week	35351
@NP	surgery	35351
@NP	once a week	35363
@NP	4.4	35386
@NP	Scar ablation	35391
@NP	photochemistry Six weeks after contusion injury the scar ablation	35410
@NP	photochemistry	35410
@NP	Six weeks	35425
@NP	contusion injury	35441
@NP	the scar ablation	35458
@NP	the injury epicenter	35493
@NP	the transplantation , as described before -LRB- Zhang et al. , 2007a -RRB-	35526
@NP	the transplantation	35526
@NP	Zhang et al. , 2007a	35568
@NP	Zhang	35568
@NP	et al.	35574
@NP	2007a	35582
@NP	deep anesthesia with sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	35605
@NP	deep anesthesia	35605
@NP	sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	35626
@NP	sodium pentobarbital	35626
@NP	50 mg/kg , i.p.	35648
@NP	50 mg/kg	35648
@NP	the wound	35665
@NP	the injury site of the spinal cord	35692
@NP	the injury site	35692
@NP	the spinal cord	35711
@NP	the dura	35755
@NP	One -LRB- 1.0 -RRB- μl of 2 %	35765
@NP	One -LRB- 1.0 -RRB- μl	35765
@NP	One -LRB- 1.0 -RRB-	35765
@NP	One	35765
@NP	1.0	35770
@NP	2 %	35781
@NP	Bengal in saline	35789
@NP	Bengal	35789
@NP	saline	35799
@NP	the lesion cavity	35831
@NP	a glass pipette	35857
@NP	a microinjector , which was fixed in a stereotaxic instrument	35886
@NP	a microinjector	35886
@NP	a stereotaxic instrument	35922
@NP	The	35948
@NP	Bengal within the cavity	35957
@NP	Bengal	35957
@NP	the cavity	35971
@NP	5 min	36009
@NP	injection	36020
@NP	the injury site	36031
@NP	5 min	36072
@NP	the full spectrum light of a halogen bulb -LRB- 150 W , 7 cm distance -RRB-	36083
@NP	the full spectrum light	36083
@NP	a halogen bulb -LRB- 150 W , 7 cm distance -RRB-	36110
@NP	a halogen bulb	36110
@NP	150 W	36126
@NP	7 cm distance	36133
@NP	unnecessary damage	36160
@NP	the heating source	36182
@NP	the halogen light	36206
@NP	the exposed part of spinal cord	36225
@NP	the exposed part	36225
@NP	spinal cord	36245
@NP	room temperature saline solution	36273
@NP	fresh change	36311
@NP	every 30 s	36324
@NP	the illumination	36342
@NP	4.5	36360
@NP	Transplantation of OECs and LP Transplantation	36365
@NP	Transplantation	36365
@NP	OECs and LP Transplantation	36384
@NP	photochemical scar ablation	36444
@NP	Zhang	36497
@NP	et al. , 2011a	36503
@NP	et al.	36503
@NP	2011a	36511
@NP	the surgical microscopy	36534
@NP	1.0 μl of OEC suspension -LRB- 6 × 106 cells -RRB-	36559
@NP	1.0 μl	36559
@NP	OEC suspension -LRB- 6 × 106 cells -RRB-	36569
@NP	OEC suspension	36569
@NP	6 × 106 cells	36585
@NP	6 ×	36585
@NP	106 cells	36587
@NP	the lesion cavity	36616
@NP	a 31 gauge needle connecting to a Hamilton syringe prior LP delivery	36642
@NP	a 31 gauge needle	36642
@NP	a Hamilton syringe	36674
@NP	LP delivery	36699
@NP	Ten minutes later	36712
@NP	the dura	36731
@NP	a 1.0 mm scission on the median line of the spinal cord at the injury epicenter	36771
@NP	a 1.0 mm scission	36771
@NP	the median line of the spinal cord at the injury epicenter	36792
@NP	the median line	36792
@NP	the spinal cord at the injury epicenter	36811
@NP	the spinal cord	36811
@NP	the injury epicenter	36830
@NP	an 11 blade	36865
@NP	the lesion cavity	36887
@NP	Two pieces of LP -LRB- 1.0 × 1.0 mm -RRB-	36906
@NP	Two pieces of LP	36906
@NP	Two pieces	36906
@NP	LP	36920
@NP	1.0 × 1.0 mm	36924
@NP	1.0 ×	36924
@NP	1.0 mm	36928
@NP	the lesion cavity	36966
@NP	the dura	36996
@NP	a 10-0 Novafil nylon suture -LRB- Ethicon , Somerville , NJ , USA -RRB-	37033
@NP	a 10-0 Novafil nylon suture	37033
@NP	Ethicon	37062
@NP	Somerville	37071
@NP	NJ , USA	37083
@NP	whichwas	37093
@NP	the dura and ready to tighten up immediately after LP delivery	37109
@NP	the dura	37109
@NP	ready to tighten up immediately after LP delivery	37122
@NP	LP	37160
@NP	the muscle and skin	37178
@NP	proper sutures	37215
@NP	4.6	37245
@NP	Tail nerve electrical stimulation The electrical stimulation	37250
@NP	Tail nerve electrical stimulation	37250
@NP	Tail nerve	37250
@NP	electrical stimulation	37261
@NP	The electrical stimulation	37284
@NP	one week	37319
@NP	basic treatments or 7 weeks	37334
@NP	basic treatments	37334
@NP	7 weeks	37354
@NP	contusion injury	37368
@NP	a physical therapy instrument	37394
@NP	Type J18A1 computer control middle frequency instrument	37425
@NP	Type J18A1 computer control	37425
@NP	middle frequency instrument	37453
@NP	Quan-Ri-Kang Company in China	37490
@NP	Quan-Ri-Kang Company	37490
@NP	China	37514
@NP	it	37521
@NP	no risk	37546
@NP	no side effect in the application in clinic and home	37558
@NP	no side effect	37558
@NP	the application in clinic and home	37576
@NP	the application	37576
@NP	clinic and home	37595
@NP	The instrument	37613
@NP	a middle frequency carrier wave of 2.5	37632
@NP	a middle frequency carrier wave	37632
@NP	2.5	37667
@NP	8 kHz and low adjustable frequency 0	37671
@NP	8 kHz	37671
@NP	low adjustable frequency 0	37681
@NP	150 Hz with a maximal output current 100mA	37708
@NP	150 Hz	37708
@NP	a maximal output current 100mA	37720
@NP	The strength of stimulation	37752
@NP	The strength	37752
@NP	stimulation	37768
@NP	the response	37809
@NP	rats to the stimulation , usually between 10 and 40mA at a frequency of 4 kHz	37825
@NP	rats to the stimulation , usually between 10	37825
@NP	rats	37825
@NP	the stimulation	37833
@NP	10	37866
@NP	40mA at a frequency of 4 kHz	37873
@NP	40mA	37873
@NP	a frequency of 4 kHz	37881
@NP	a frequency	37881
@NP	4 kHz	37896
@NP	TANES	37903
@NP	Zhang et al. , 2010	37948
@NP	Zhang	37948
@NP	et al.	37954
@NP	2010	37962
@NP	anesthesia	37986
@NP	the rat	37997
@NP	an open field -LRB- plastic swimming pool with a diameter of 4 ft -RRB-	38016
@NP	an open field	38016
@NP	plastic swimming pool with a diameter of 4 ft	38031
@NP	plastic swimming pool	38031
@NP	a diameter of 4 ft	38058
@NP	a diameter	38058
@NP	4 ft	38072
@NP	The rat 's tail	38079
@NP	The rat 's	38079
@NP	the instrument with two electrodes	38116
@NP	the instrument	38116
@NP	two electrodes	38136
@NP	the stimulation current	38157
@NP	the rat 's tail	38189
@NP	the rat 's	38189
@NP	the two hind limbs	38205
@NP	tomove	38232
@NP	The rats	38270
@NP	step	38302
@NP	the open field	38335
@NP	the stimulation	38357
@NP	possiblemuscle fatigue	38385
@NP	the over movement of the leg muscle	38415
@NP	the over movement	38415
@NP	the leg muscle	38436
@NP	the movement of the hind limb	38452
@NP	the movement	38452
@NP	the hind limb	38468
@NP	40 -- 60 steps per minute	38497
@NP	40	38497
@NP	60 steps per minute	38500
@NP	60 steps	38500
@NP	minute	38513
@NP	the stimulating strength	38534
@NP	The electrical stimulation	38560
@NP	20 min per session , 5 sessions a week ,	38594
@NP	20 min	38594
@NP	session , 5 sessions a week ,	38605
@NP	session	38605
@NP	5 sessions a week	38614
@NP	5 sessions	38614
@NP	a week	38625
@NP	a total of 15 weeks	38637
@NP	a total	38637
@NP	15 weeks	38648
@NP	4.7	38658
@NP	Evaluation of hind limb locomotor function The neurological outcome	38663
@NP	Evaluation	38663
@NP	hind limb locomotor function The neurological outcome	38677
@NP	hind limb locomotor function	38677
@NP	The neurological outcome	38706
@NP	three independent people	38748
@NP	thewell-knownopen field locomotion rating scale	38779
@NP	BBB scale	38828
@NP	Basso	38839
@NP	et al. , 1995 , 1996	38845
@NP	et al.	38845
@NP	1995	38853
@NP	1996	38859
@NP	contusion injury	38872
@NP	the BBB scores	38890
@NP	1 day , 3 days , 7 days post-injury and once aweek	38920
@NP	1 day	38920
@NP	3 days	38927
@NP	7 days post-injury	38935
@NP	once aweek	38958
@NP	addition	38983
@NP	a video record -LRB- 1 to 2minute long each time -RRB-	38993
@NP	a video record	38993
@NP	1 to 2minute long each time	39009
@NP	1	39009
@NP	2minute long each time	39014
@NP	weekly for each rat	39047
@NP	weekly	39047
@NP	each rat	39058
@NP	The moving patterns of the hind limbswere	39068
@NP	The moving patterns	39068
@NP	the hind limbswere	39091
@NP	carefullywith	39119
@NP	the help of slowmotion video records	39133
@NP	the help	39133
@NP	slowmotion video records	39145
@NP	The final BBB score for each time point	39171
@NP	The final BBB score	39171
@NP	each time point	39195
@NP	the BBB paper record	39239
@NP	the results of the video record review	39265
@NP	the results	39265
@NP	the video record review	39280
@NP	detail , the individual movements of hind limb	39321
@NP	detail	39321
@NP	the individual movements of hind limb	39329
@NP	the individual movements	39329
@NP	hind limb	39357
@NP	the locomotion in an open field	39374
@NP	the locomotion	39374
@NP	an open field	39392
@NP	kinematic analysis	39407
@NP	the videotaped recordings	39449
@NP	the modified Peak Performance Movement Analysis System	39481
@NP	Coumans	39537
@NP	et al. , 2001 ; Muir and Webb , 2000	39545
@NP	et al.	39545
@NP	2001 ; Muir and Webb	39553
@NP	2001	39553
@NP	Muir and Webb	39559
@NP	2000	39574
@NP	Stepping cycles	39581
@NP	the movement pattern	39617
@NP	Rats from different groups	39657
@NP	Rats	39657
@NP	different groups	39667
@NP	the end of the experiment	39701
@NP	the end	39701
@NP	the experiment	39712
@NP	The locomotion pattern of normal rat 's stepping cycle	39728
@NP	The locomotion pattern	39728
@NP	normal rat 's stepping cycle	39754
@NP	normal rat 's	39754
@NP	a standard for comparison	39794
@NP	a standard	39794
@NP	comparison	39809
@NP	other rats	39825
@NP	different treatments	39841
@NP	the videotaped recordings	39876
@NP	a stepping cycle of uninjured rat	39903
@NP	a stepping cycle	39903
@NP	uninjured rat	39923
@NP	beginning , middle ,	39956
@NP	beginning	39956
@NP	middle	39967
@NP	phases	39986
@NP	a middle swing phase and a phase in stance -LRB- Fig. 2 -RRB-	39999
@NP	a middle swing phase	39999
@NP	a phase in stance -LRB- Fig. 2 -RRB-	40024
@NP	a phase	40024
@NP	stance -LRB- Fig. 2 -RRB-	40035
@NP	stance	40035
@NP	Fig. 2	40043
@NP	4.8	40052
@NP	Fast blue retrograde tracing The retrograde tracing with fast blue	40057
@NP	Fast blue retrograde	40057
@NP	Fast	40057
@NP	The retrograde	40086
@NP	fast blue	40114
@NP	neurons	40149
@NP	the cortex and brainstem with their axons	40160
@NP	the cortex and brainstem	40160
@NP	their axons	40190
@NP	the injury site	40239
@NP	3 or 22weeks after contusion injury	40255
@NP	3 or 22weeks	40255
@NP	contusion injury	40274
@NP	deep anesthesia with pentobarbital -LRB- 50mg/kg , i.p. -RRB-	40298
@NP	deep anesthesia	40298
@NP	pentobarbital -LRB- 50mg/kg , i.p. -RRB-	40319
@NP	pentobarbital	40319
@NP	50mg/kg , i.p.	40334
@NP	50mg/kg	40334
@NP	the wound	40350
@NP	the injury site	40378
@NP	One -LRB- 1.0 -RRB- μl of 2.0 %	40407
@NP	One -LRB- 1.0 -RRB- μl	40407
@NP	One -LRB- 1.0 -RRB-	40407
@NP	One	40407
@NP	1.0	40412
@NP	2.0 %	40423
@NP	aqueous suspension of fast blue -LRB- Sigma , St.	40428
@NP	aqueous suspension	40428
@NP	fast blue -LRB- Sigma , St.	40450
@NP	fast blue	40450
@NP	Sigma	40461
@NP	St.	40468
@NP	Louis	40472
@NP	MO	40479
@NP	the cord 1.5 mmcaudal to the injury site with one or two injections	40500
@NP	the cord 1.5 mmcaudal	40500
@NP	the injury site with one or two injections	40524
@NP	the injury site	40524
@NP	one or two injections	40545
@NP	a glass pipette	40576
@NP	a 10 μlmicroinjector , which was fixed in a stereotaxic instrument	40604
@NP	a 10 μlmicroinjector	40604
@NP	a stereotaxic instrument	40644
@NP	Seven days	40670
@NP	animals	40696
@NP	phosphate-buffered 4 % paraformaldehyde	40738
@NP	The brain and the cord	40778
@NP	The brain	40778
@NP	the cord	40792
@NP	post-fixed overnight at the same fixative	40818
@NP	post-fixed overnight	40818
@NP	the same fixative	40842
@NP	20 % sucrose in 0.1 M phosphate buffer	40885
@NP	20 % sucrose	40885
@NP	0.1 M phosphate buffer	40900
@NP	pH 7.4	40924
@NP	The whole brain including the brainstem	40933
@NP	The whole brain	40933
@NP	the brainstem	40959
@NP	a cryostat	40999
@NP	40 μm thick sections	41015
@NP	40 μm	41015
@NP	glass slides	41069
@NP	The samples	41083
@NP	a fluorescence microscope	41115
@NP	The position of each labeled neuron	41142
@NP	The position	41142
@NP	each labeled neuron	41158
@NP	each	41158
@NP	neuron	41171
@NP	order	41193
@NP	the same neuronmore	41217
@NP	once	41242
@NP	The labeled neurons	41248
@NP	the motor cortex	41271
@NP	nuclei	41292
@NP	the brainstem	41302
@NP	the hind limb locomotion	41327
@NP	red nucleus	41360
@NP	lateral vestibular nucleus	41373
@NP	reticular formation	41401
@NP	raphe nucleus	41422
@NP	locus coeruleus	41441
@NP	each rat	41485
@NP	4.9	41495
@NP	Histology and immunohistochemistry	41500
@NP	Histology	41500
@NP	immunohistochemistry	41514
@NP	perfusion	41553
@NP	the spinal cords	41564
@NP	the identical fixative overnight	41607
@NP	All spinal cords	41641
@NP	histological evaluation	41677
@NP	i.e.	41702
@NP	the paraffin sections	41708
@NP	10 μmthick	41731
@NP	the middle of injury epicenter	41762
@NP	the middle	41762
@NP	injury epicenter	41776
@NP	hematoxylin and eosin , H.E.	41816
@NP	hematoxylin and eosin	41816
@NP	H.E.	41839
@NP	immunostaining	41876
@NP	the sections	41892
@NP	xylene	41928
@NP	a series of ethanols and distilled water	41953
@NP	a series	41953
@NP	ethanols and distilled water	41965
@NP	ethanols	41965
@NP	distilled water	41978
@NP	Sections	42003
@NP	the Antigen Retrieval Citra solution -LRB- BioGenex , San Ramon , CA -RRB-	42027
@NP	the Antigen Retrieval Citra solution	42027
@NP	BioGenex	42065
@NP	San Ramon	42075
@NP	CA	42086
@NP	15 min	42094
@NP	the endogenous peroxidase	42111
@NP	the sections	42137
@NP	3 % H2O2	42170
@NP	50mM Tris-buffered saline	42181
@NP	0.1 % Triton X - 100 -LRB- TTBS -RRB- pH 7.5 ,	42218
@NP	0.1 % Triton X	42218
@NP	100 -LRB- TTBS -RRB- pH 7.5	42233
@NP	100 -LRB- TTBS -RRB-	42233
@NP	pH 7.5	42244
@NP	30 min at room temperature	42256
@NP	30 min	42256
@NP	room temperature	42266
@NP	RT	42284
@NP	The normal goat serum -LRB- 2 % in TTBS -RRB-	42289
@NP	The normal goat serum	42289
@NP	2 % in TTBS	42311
@NP	2 %	42311
@NP	TTBS	42316
@NP	60 min at RT	42332
@NP	60 min	42332
@NP	RT	42342
@NP	the tissue	42349
@NP	blocknon-specific antigens	42363
@NP	incubatedwith primary antibodies	42403
@NP	TTBS with 1 % normal goat serum	42447
@NP	TTBS	42447
@NP	1 % normal goat serum	42457
@NP	a humidified chamber overnight	42481
@NP	RT	42515
@NP	the sections	42519
@NP	1:200	42561
@NP	goat anti-mouse IgG -LRB- Jackson -RRB- for 60 min and then	42580
@NP	goat anti-mouse IgG -LRB- Jackson -RRB-	42580
@NP	goat anti-mouse IgG	42580
@NP	Jackson	42601
@NP	60 min and then	42614
@NP	60 min	42614
@NP	then	42625
@NP	1:500 streptavidin peroxidase -LRB- Jackson -RRB-	42633
@NP	1:500 streptavidin peroxidase	42633
@NP	Jackson	42664
@NP	60 min in the same buffer	42677
@NP	60 min	42677
@NP	the same buffer	42686
@NP	The immunoreactive product was visualized by incubating in 3,3 ′	42703
@NP	The immunoreactive product	42703
@NP	3,3 ′	42762
@NP	3,3	42762
@NP	diaminobenzidine solution -LRB- DAB , 0.5 mgin 1 ml TTBS -RRB-	42767
@NP	diaminobenzidine solution	42767
@NP	DAB , 0.5 mgin 1 ml TTBS	42794
@NP	DAB , 0.5 mgin	42794
@NP	DAB	42794
@NP	0.5 mgin	42799
@NP	1 ml TTBS	42808
@NP	0.01 % H2O2 for 1	42823
@NP	0.01 % H2O2	42823
@NP	1	42837
@NP	3 min	42839
@NP	3	42839
@NP	min	42840
@NP	The sectionswere rinsed , dehydrated ,	42845
@NP	The sectionswere rinsed	42845
@NP	hematoxylin	42936
@NP	Negative controls	42949
@NP	the lack of the primary antibody	42998
@NP	the lack	42998
@NP	the primary antibody	43010
@NP	The primary antibodies	43032
@NP	this study	43064
@NP	monoclonal antibody	43079
@NP	glial fibrillary acidic protein	43107
@NP	GFAP , 1:1000 ; Neomarker , Fremont , CA	43140
@NP	GFAP	43140
@NP	1:1000 ; Neomarker	43146
@NP	1:1000	43146
@NP	Neomarker	43154
@NP	Fremont , CA	43165
@NP	astrocytes	43181
@NP	monoclonal antibody against peripheral myelin protein -LRB- P0 , 1:1000	43193
@NP	monoclonal antibody	43193
@NP	peripheral myelin protein -LRB- P0 , 1:1000	43221
@NP	peripheral myelin protein	43221
@NP	P0	43248
@NP	1:1000	43252
@NP	courtesy of Dr.	43260
@NP	courtesy	43260
@NP	Dr.	43272
@NP	Archelos , Austria	43276
@NP	Archelos	43276
@NP	Austria	43286
@NP	Schwann cells	43298
@NP	α-p75NTR antibody	43313
@NP	OECs and Schwann cells -LRB- 1:100 ; Abcam , Cambridge , MA -RRB- ,	43348
@NP	OECs and Schwann cells	43348
@NP	1:100 ; Abcam , Cambridge , MA	43372
@NP	1:100	43372
@NP	Abcam , Cambridge , MA	43379
@NP	monoclonal antibody	43406
@NP	neurofilaments -LRB- NF -RRB- -LRB- 1:200 ; Neomarker , Fremont , CA -RRB-	43434
@NP	neurofilaments -LRB- NF -RRB-	43434
@NP	neurofilaments	43434
@NP	NF	43450
@NP	1:200 ; Neomarker , Fremont , CA	43455
@NP	1:200	43455
@NP	Neomarker , Fremont , CA	43462
@NP	4.10	43487
@NP	Measurement	43493
@NP	repaired tissue and lesion cavity	43508
@NP	tissue	43549
@NP	the remaining peripheral rim of spinal cord tissue	43559
@NP	the remaining peripheral rim	43559
@NP	spinal cord tissue	43591
@NP	the weight-drop contusion	43624
@NP	a central cord lesion cavity	43668
@NP	the injury epicenter -LRB- Basso et al. , 1996 ; Beattie et al. , 1997 -RRB-	43700
@NP	the injury epicenter	43700
@NP	Basso	43722
@NP	et al. , 1996 ; Beattie et al. , 1997	43728
@NP	et al.	43728
@NP	1996 ; Beattie et al.	43736
@NP	1996	43736
@NP	Beattie et al.	43742
@NP	Beattie	43742
@NP	et al.	43750
@NP	1997	43758
@NP	The spared tissue	43765
@NP	fibers	43799
@NP	Figs. 5A , B	43828
@NP	tissue	43851
@NP	a newly formed tissue from the dorsal lesion cavity at the injury site	43861
@NP	a newly formed tissue	43861
@NP	the dorsal lesion cavity at the injury site	43888
@NP	the dorsal lesion cavity	43888
@NP	the injury site	43916
@NP	The repaired tissue	43933
@NP	structure from the normal cord tissue	43969
@NP	structure	43969
@NP	the normal cord tissue	43984
@NP	Schwann cells , some fibroblasts	44038
@NP	Schwann cells	44038
@NP	some fibroblasts	44053
@NP	newly formed blood vessels	44071
@NP	regenerating axons -LRB- Zhang et al. , 2011b -RRB-	44102
@NP	regenerating axons	44102
@NP	Zhang	44122
@NP	et al. , 2011b	44128
@NP	et al.	44128
@NP	2011b	44136
@NP	the repaired tissue	44155
@NP	almost no astrocytes	44184
@NP	the changes of repaired tissues	44260
@NP	the changes	44260
@NP	repaired tissues	44275
@NP	lesion cavities in size	44296
@NP	lesion cavities	44296
@NP	size	44315
@NP	the whole area of spinal cord cross section at the injury epicenter	44321
@NP	the whole area	44321
@NP	spinal cord cross section at the injury epicenter	44339
@NP	spinal cord cross section	44339
@NP	the injury epicenter	44368
@NP	the areas of spared tissues , repaired tissues and lesion cavities	44394
@NP	the areas	44394
@NP	spared tissues , repaired tissues and lesion cavities	44407
@NP	spared tissues	44407
@NP	tissues and lesion cavities	44432
@NP	The paraffin sections	44486
@NP	hematoxylin and eosin	44526
@NP	the measurementwas	44552
@NP	each case with Soft Imaging System GmbH	44585
@NP	each case	44585
@NP	Soft Imaging System GmbH	44600
@NP	Version 1.20	44626
@NP	Olympus	44640
@NP	The average percentage	44650
@NP	spared tissues	44676
@NP	tissues and lesion cavities	44701
@NP	the whole area of cross section in each group	44732
@NP	the whole area	44732
@NP	cross section in each group	44750
@NP	cross section	44750
@NP	each group	44767
@NP	Mean ± SEM	44796
@NP	the comparisons between groups	44810
@NP	the comparisons	44810
@NP	groups	44834
@NP	4.11	44859
@NP	Collection	44865
@NP	quantitative data of P0-positive myelination P0-positive myelin sheaths	44879
@NP	quantitative data	44879
@NP	P0-positive myelination P0-positive myelin sheaths	44900
@NP	P0-positive myelination	44900
@NP	P0-positive myelin sheaths	44924
@NP	Schwann cells that can be found in the repaired tissue	44979
@NP	Schwann cells	44979
@NP	the repaired tissue	45014
@NP	the spared tissue at the injury site -LRB- Zhang et al. , 2011b -RRB-	45048
@NP	the spared tissue	45048
@NP	the injury site -LRB- Zhang et al. , 2011b -RRB-	45069
@NP	the injury site	45069
@NP	Zhang	45086
@NP	et al. , 2011b	45092
@NP	et al.	45092
@NP	2011b	45100
@NP	our previous study	45111
@NP	the quantitative data	45131
@NP	P0 - positive myelination obtained from the injury epicenter	45156
@NP	P0	45156
@NP	positive myelination obtained from the injury epicenter	45160
@NP	positive myelination	45160
@NP	the injury epicenter	45195
@NP	the trend of axonal regeneration	45238
@NP	the trend	45238
@NP	axonal regeneration	45251
@NP	this purpose	45276
@NP	the number of P0-positive myelin sheaths	45290
@NP	the number	45290
@NP	P0-positive myelin sheaths	45304
@NP	the light microscope -LRB- magnification : 40 × -RRB-	45349
@NP	the light microscope	45349
@NP	magnification : 40 ×	45371
@NP	magnification	45371
@NP	40 ×	45386
@NP	Zhang	45416
@NP	et al. , 2011a	45422
@NP	et al.	45422
@NP	2011a	45430
@NP	2	45447
@NP	3 histological sections	45449
@NP	P0-immunostaining	45478
@NP	injury epicenter of each case	45501
@NP	injury epicenter	45501
@NP	each case	45521
@NP	the counting	45545
@NP	All P0-positive myelin sheaths	45559
@NP	the repaired tissue	45593
@NP	lesion cavity	45614
@NP	tissue	45639
@NP	the transverse sections	45649
@NP	the injury epicenter	45676
@NP	n ≥ 4 each group	45711
@NP	n	45711
@NP	≥ 4 each group	45712
@NP	≥ 4	45712
@NP	each group	45715
@NP	the spared tissue	45736
@NP	spared/demyelinated fibers	45766
@NP	regenerating axons myelinated by Schwann cells -LRB- Zhang et al. , 2007a -RRB-	45797
@NP	regenerating axons	45797
@NP	Schwann cells -LRB- Zhang et al. , 2007a -RRB-	45830
@NP	Schwann cells	45830
@NP	Zhang	45845
@NP	et al. , 2007a	45851
@NP	et al.	45851
@NP	2007a	45859
@NP	the counting area	45867
@NP	the spared tissue	45894
@NP	all counted P0-positive myelin sheaths within the counting area	45921
@NP	all	45921
@NP	P0-positive myelin sheaths	45933
@NP	the counting area	45967
@NP	a total number for each case	46002
@NP	a total number	46002
@NP	each case	46021
@NP	The counts of P0-positive myelin sheaths in each group	46032
@NP	The counts	46032
@NP	P0-positive myelin sheaths in each group	46046
@NP	P0-positive myelin sheaths	46046
@NP	each group	46076
@NP	Mean ± SEM	46105
@NP	4.12	46115
@NP	Statistical analysis All quantitative data	46121
@NP	Statistical analysis	46121
@NP	All quantitative data	46142
@NP	Mean ± SEM	46182
@NP	field locomotor scores -LRB- BBB scores -RRB-	46197
@NP	field locomotor scores	46197
@NP	BBB scores	46221
@NP	the hind limbs	46237
@NP	the same group	46257
@NP	one score for each time point	46295
@NP	one score	46295
@NP	each time point	46309
@NP	The BBB scores	46326
@NP	a two-way analysis	46361
@NP	variance -LRB- ANOVA -RRB- between any two groups	46383
@NP	variance -LRB- ANOVA -RRB-	46383
@NP	variance	46383
@NP	ANOVA	46393
@NP	any two groups	46408
@NP	between the 6th week post-injury and the end of experiment	46427
@NP	the 6th week post-injury	46435
@NP	week	46443
@NP	the end of experiment	46464
@NP	the end	46464
@NP	experiment	46475
@NP	each individual group	46490
@NP	The areas of repaired tissue , lesion cavity and spared tissue	46513
@NP	The areas	46513
@NP	tissue , lesion cavity	46535
@NP	tissue	46568
@NP	percentage	46592
@NP	the whole area of the spinal cord	46606
@NP	the whole area	46606
@NP	the spinal cord	46624
@NP	the injury epicenter for each case	46643
@NP	the injury epicenter	46643
@NP	each case	46668
@NP	one-way ANOVAs	46683
@NP	comparison of repaired tissue , lesion cavity and spared tissue between groups	46716
@NP	comparison	46716
@NP	tissue , lesion cavity	46739
@NP	tissue between groups	46772
@NP	tissue	46772
@NP	groups	46787
@NP	All P0-positive myelin sheaths	46795
@NP	the counting area of injury epicenter excluding the dorsal and ventral roots	46829
@NP	the counting area	46829
@NP	injury epicenter excluding the dorsal and ventral roots	46850
@NP	injury epicenter	46850
@NP	the dorsal and ventral roots	46877
@NP	the dorsal	46877
@NP	ventral roots	46892
@NP	each group	46938
@NP	the between-group comparisons	46950
@NP	one-way ANOVAs	47001
@NP	Neurons labeled with fast blue tracer	47017
@NP	Neurons	47017
@NP	fast blue tracer	47038
@NP	nuclei	47068
@NP	nuclei	47078
@NP	statistical analyses	47086
@NP	differences	47110
@NP	groups	47130
@NP	the number of FB-labeled neurons -LRB- nuclei by nuclei and total -RRB-	47140
@NP	the number	47140
@NP	FB-labeled neurons -LRB- nuclei by nuclei and total -RRB-	47154
@NP	FB-labeled neurons	47154
@NP	nuclei by nuclei and total	47174
@NP	nuclei	47174
@NP	nuclei and total	47184
@NP	one-way ANOVAs	47222
@NP	all cases	47241
@NP	the analysis of quantitative data	47252
@NP	the analysis	47252
@NP	quantitative data	47268
@NP	overall significance followed by a post hoc LSD Student 's t test	47304
@NP	overall significance	47304
@NP	a post hoc LSD Student 's t test	47337
@NP	a post hoc LSD	47337
@NP	a post	47337
@NP	Student 's t test	47352
@NP	Student 's	47352
@NP	differences	47370
@NP	p	47413
@NP	Relationship	47421
@NP	FBlabeled neurons from cortex and nuclei of brainstem and the BBB scores	47442
@NP	FBlabeled neurons from cortex	47442
@NP	FBlabeled neurons	47442
@NP	cortex	47465
@NP	nuclei of brainstem and the BBB scores	47476
@NP	nuclei	47476
@NP	brainstem and the BBB scores	47486
@NP	brainstem	47486
@NP	the BBB scores	47500
@NP	linear regression	47534
@VP	applying cellular transplantation to the chronically injured spinal cord	266
@VP	have yielded significant functional improvement in animal experiments	339
@VP	yielded significant functional improvement in animal experiments	344
@VP	inducing active weight-supported stepping	678
@VP	stepping	711
@VP	produced by using the NYU impactor device in female , adult Long -- Evans rats	769
@VP	using the NYU impactor device in female , adult Long -- Evans rats	781
@VP	followed by transplantation of lamina propria of olfactory mucosa	918
@VP	cultured olfactory ensheathing cells into the lesion cavity	988
@VP	were subjected to TANES one week after secondary surgery or 7 weeks after SCI	1112
@VP	subjected to TANES one week after secondary surgery or 7 weeks after SCI	1117
@VP	to TANES one week after secondary surgery or 7 weeks after SCI	1127
@VP	TANES one week after secondary surgery or 7 weeks after SCI	1130
@VP	receiving TANES	1270
@VP	evaluated with BBB open field rating scale -LRB- p < 0.01 -RRB-	1375
@VP	performed better than those without basic treatments	1476
@VP	is critical for functional recovery	1618
@VP	may promote axonal regeneration , including those from supraspinal level	1675
@VP	promote axonal regeneration , including those from supraspinal level	1679
@VP	achieving improvement of functional recovery in rat model	1800
@VP	would suggest a new strategy for chronic SCI	1862
@VP	suggest a new strategy for chronic SCI	1868
@VP	1	1909
@VP	applying cellular transplantation to the chronically injured	1957
@VP	contused	2030
@VP	cultured OEC into the lesion cavity immediately after scar ablation	2799
@VP	repaired tissue	3044
@VP	result in significant locomotor recovery -LRB- Zhang et al. , 2011a -RRB-	3355
@VP	induced by locomotor training below the injury level of the spinal cord	3504
@VP	is a necessary component	3769
@VP	occurs at both the supraspinal and spinal levels after SCI	4164
@VP	may not be strong enough to allow functional recovery	4227
@VP	be strong enough to allow functional recovery	4235
@VP	to allow functional recovery	4252
@VP	allow functional recovery	4255
@VP	is necessary for functional recovery promoted or triggered by physical therapy	4311
@VP	promoted or triggered by physical therapy	4348
@VP	promoted	4348
@VP	triggered by physical therapy	4360
@VP	to reinforce both voluntary aspects of locomotion	4487
@VP	reinforce both voluntary aspects of locomotion	4490
@VP	to reinforce endogenous spinal mechanisms -LRB- Rossignol et al. , 2007 -RRB-	4548
@VP	reinforce endogenous spinal mechanisms -LRB- Rossignol et al. , 2007 -RRB-	4551
@VP	increase the levels of NT-3 and BDNF in the motor neurons and muscle fibers	4971
@VP	are reported to be noninvasive	5919
@VP	reported to be noninvasive	5923
@VP	to be noninvasive	5932
@VP	be noninvasive	5935
@VP	trigger the activation of the CPG below the lesion level through the tail nerves	6075
@VP	stepping with characteristic features of active , alternative movement of left	6209
@VP	alternating limbs during tail pinch -LRB- Meisel and Rakerd , 1982 -RRB-	6536
@VP	enabled the SCI patient to achieve full weight-bear standing	6683
@VP	to achieve full weight-bear standing	6707
@VP	achieve full weight-bear standing	6710
@VP	stepping with assistance during stimulation -LRB- Harkema et al. , 2011 -RRB-	6748
@VP	would control the hind limb locomotion	7247
@VP	control the hind limb locomotion	7253
@VP	2	7550
@VP	started	7696
@VP	show functional improvement in the group either with or without basic treatments	7719
@VP	only control rats nor rats with basic treatments	7825
@VP	show notable improvement of functional recovery	7880
@VP	stepping cycle	8248
@VP	shows the bony landmarks of hind limbs related to the locomotion	8267
@VP	related to the locomotion	8306
@VP	ending phase , and middle swing ,	8434
@VP	to stand up in stance with the support of the wall through their front limbs	8578
@VP	stand up in stance with the support of the wall through their front limbs	8581
@VP	represents the ground surface of the open field	8700
@VP	saved from the video records	8804
@VP	could not support the body weightmost of the time -LRB- arrowheads in A -RRB-	8999
@VP	support the body weightmost of the time -LRB- arrowheads in A -RRB-	9009
@VP	stepping -LRB- arrows in B -RRB-	9260
@VP	is shown 14 weeks after combination treatments of the same rat -LRB- C -RRB-	9348
@VP	shown 14 weeks after combination treatments of the same rat -LRB- C -RRB-	9351
@VP	compared with a normal rat -LRB- D -RRB- the postures of these two rats	9421
@VP	look quite similar	9483
@VP	left hind limb -LRB- LH -RRB- were moving forward	9549
@VP	were moving forward	9569
@VP	moving forward	9574
@VP	were getting ready to move	9640
@VP	getting ready to move	9645
@VP	to move	9659
@VP	move	9662
@VP	show the lesion area and spared tissue demarked by GFAP -LRB- arrows , A -RRB-	9810
@VP	show the lesion area	9810
@VP	spared tissue demarked by GFAP -LRB- arrows , A -RRB-	9835
@VP	demarked by GFAP -LRB- arrows , A -RRB-	9849
@VP	filled with p75NTR positive cells except in some tiny cysts -LRB- * , B -RRB-	9899
@VP	were found in the lesion area and spared tissue -LRB- C -RRB-	9996
@VP	were found in the lesion area	9996
@VP	found in the lesion area	10001
@VP	spared tissue -LRB- C -RRB-	10030
@VP	appeared at the interfaces -LRB- broken lines -RRB- between spared tissue	10062
@VP	ends of the cord	10177
@VP	are cross sections at the injury epicenter from different groups	10307
@VP	are their local magnifications , respectively	10404
@VP	are H.E. staining while those in the right column are GFAP immunostaining	10488
@VP	are GFAP immunostaining	10538
@VP	Spared tissue , lesion cavity , and repaired tissue	10563
@VP	Spared tissue , lesion cavity ,	10563
@VP	repaired tissue	10597
@VP	are clearly labeled	10613
@VP	labeled	10625
@VP	are indicated by the arrows	10666
@VP	indicated by the arrows	10670
@VP	are remarkable	10832
@VP	are nearly unobserved	10915
@VP	spared tissue	11031
@VP	are shown	11325
@VP	shown	11329
@VP	compared with the control group	11476
@VP	repaired tissue	11735
@VP	spared tissue -LRB- ST -RRB- , besides in the dorsal roots -LRB- DR -RRB-	11755
@VP	marked by asterisks -LRB- * -RRB-	11855
@VP	contains numerous P0-positive myelin sheaths , which are magnified in C.	11879
@VP	are magnified in C.	11931
@VP	magnified in C.	11935
@VP	appear as small circles or dots in brown	11982
@VP	are indicated by the arrowheads	12041
@VP	indicated by the arrowheads	12045
@VP	stained by hematoxylin	12089
@VP	may belong to Schwann cells	12112
@VP	belong to Schwann cells	12116
@VP	are directly shown in the histogram	12293
@VP	shown in the histogram	12306
@VP	labeled neurons	12368
@VP	observed under the fluorescence microscope	12496
@VP	labeled neuronal cell bodies	12545
@VP	are pointed by the arrows	12574
@VP	pointed by the arrows	12578
@VP	see Table 1	12874
@VP	are directly shown in each individual histogram	12901
@VP	shown in each individual histogram	12914
@VP	tracing	13079
@VP	were plotted against the BBB scores	13087
@VP	plotted against the BBB scores	13092
@VP	did not have their BBB scores markedly	13496
@VP	have their BBB scores markedly	13504
@VP	started	14216
@VP	showed obvious improvement of functional recovery	14283
@VP	is statistically significant -LRB- p < 0.01 -RRB- -LRB- Fig. 1 -RRB-	14588
@VP	eight weeks after treatments	14740
@VP	stay on a plateau until the end of the observation at 22 weeks after contusion	14779
@VP	was characterized by weightsupported hind limb plantar stepping pattern	15081
@VP	characterized by weightsupported hind limb plantar stepping pattern	15085
@VP	stepping pattern	15136
@VP	is held highly over the ground	15163
@VP	held highly over the ground	15166
@VP	is always forward	15205
@VP	are parallel to the longitudinal axis of the body	15239
@VP	have no contact with the ground surface	15318
@VP	can stand up with the support of front limbs holding the wall	15387
@VP	stand up with the support of front limbs holding the wall	15391
@VP	holding the wall	15432
@VP	show a certain degree of spontaneous recovery of function	15495
@VP	is face down and forward laterally	15603
@VP	face down and forward laterally	15606
@VP	are able to flex their ankles and able to support the body weight in stance	15675
@VP	to flex their ankles	15684
@VP	flex their ankles	15687
@VP	to support the body weight in stance	15714
@VP	support the body weight in stance	15717
@VP	continue to touch the ground	15768
@VP	to touch the ground	15777
@VP	touch the ground	15780
@VP	are not able to support their body weight during continuous stepping	15818
@VP	to support their body weight during continuous stepping	15831
@VP	support their body weight during continuous stepping	15834
@VP	stepping	15878
@VP	are able to support the body weight with plantar stepping consistently	15962
@VP	to support the body weight with plantar stepping consistently	15971
@VP	support the body weight with plantar stepping consistently	15974
@VP	stepping consistently	16011
@VP	touch the ground	16056
@VP	are forward but still rotate slightly and laterally	16085
@VP	rotate slightly and laterally	16107
@VP	can stand up with the front limbs holding the wall	16166
@VP	stand up with the front limbs holding the wall	16170
@VP	holding the wall	16200
@VP	do not appear to be as strong as normal rats	16222
@VP	appear to be as strong as normal rats	16229
@VP	to be as strong as normal rats	16236
@VP	be as strong as normal rats	16239
@VP	touch the ground during the swing	16300
@VP	is pretty close to the normal rats	16362
@VP	compared with SCI control rats	16553
@VP	does not appear to function as well as rats with full treatments	16605
@VP	appear to function as well as rats with full treatments	16614
@VP	to function as well as rats with full treatments	16621
@VP	function as well as rats with full treatments	16624
@VP	function	16624
@VP	rats with full treatments	16644
@VP	was shown in Fig. 3	16748
@VP	shown in Fig. 3	16752
@VP	to support her bodyweight with her two hind limbs when dragging	16818
@VP	support her bodyweight with her two hind limbs when dragging	16821
@VP	dragging	16873
@VP	supported stepping characterized by left	17028
@VP	stepping characterized by left	17038
@VP	characterized by left	17047
@VP	compared with a normal rat	17203
@VP	were perfused 4 weeks after basic treatments and the spinal cords	17408
@VP	perfused 4 weeks after basic treatments and the spinal cords	17413
@VP	were processed for longitudinal section	17474
@VP	processed for longitudinal section	17479
@VP	show the spared tissue and lesion area	17642
@VP	contribute to the tissue repair	17811
@VP	regenerating	17903
@VP	indicating that these regenerating axons entered or left lesion area	18090
@VP	entered or left lesion area	18131
@VP	entered	18131
@VP	left lesion area	18142
@VP	spared tissue -LRB- Fig. 4 -RRB-	18162
@VP	is located at the inner edge of the spared tissue	18450
@VP	labeled with GFAP immunoreaction	18504
@VP	was clearly identified	18537
@VP	clearly identified	18541
@VP	was found slightly expanded -LRB- 60.31 ± 6.29 % -RRB-	18605
@VP	found slightly expanded -LRB- 60.31 ± 6.29 % -RRB-	18609
@VP	remained	18720
@VP	repaired tissue -LRB- 87.81 ± 0.99 % in Group 3	18791
@VP	occupied the damaged area	18874
@VP	repaired tissue with spared tissue ; simultaneously	19030
@VP	spared tissue ; simultaneously	19051
@VP	could be identified	19124
@VP	be identified	19130
@VP	identified	19133
@VP	observed before these P0-positive myelin sheaths	19446
@VP	were found in the repaired tissue , lesion cavity	19495
@VP	found in the repaired tissue , lesion cavity	19500
@VP	spared tissue -LRB- Figs. 7A -- C -RRB-	19548
@VP	might be formed by the host Schwann cells	19581
@VP	be formed by the host Schwann cells	19587
@VP	formed by the host Schwann cells	19590
@VP	may include regenerating axons -LRB- in the repaired tissue -RRB-	19646
@VP	include regenerating axons -LRB- in the repaired tissue -RRB-	19650
@VP	may be ascending or descending axons	19766
@VP	be ascending or descending axons	19770
@VP	ascending or descending axons	19773
@VP	are shown as Mean ± SEM	19859
@VP	shown as Mean ± SEM	19863
@VP	are statistically significant -LRB- p < 0.05 -RRB- -LRB- Fig. 7D -RRB-	20106
@VP	survived the contusion injury	20419
@VP	were listed in Table 1 and shown in Fig. 8	20638
@VP	listed in Table 1 and shown in Fig. 8	20643
@VP	listed in Table 1	20643
@VP	shown in Fig. 8	20665
@VP	compared with that from Group 1 -LRB- SCI 22w -RRB-	20975
@VP	is not statistically significant	21037
@VP	show a significant increase in the number of labeled neurons	21119
@VP	is statistically significant -LRB- p < 0.05 -RRB-	21236
@VP	show 10 times more labeled neurons than that in Group 1	21561
@VP	labeled neurons than that in Group 1	21580
@VP	tracing	21868
@VP	were plotted against the BBB open field locomotor scores	21876
@VP	plotted against the BBB open field locomotor scores	21881
@VP	3	22073
@VP	walking induced by TANES	22383
@VP	induced by TANES	22391
@VP	can be transformed into permanent ability to walk , namely functional recovery	22408
@VP	be transformed into permanent ability to walk , namely functional recovery	22412
@VP	transformed into permanent ability to walk , namely functional recovery	22415
@VP	to walk	22450
@VP	walk	22453
@VP	based on the tissue repair and axonal regeneration	22572
@VP	may be promoted by the activation of the CPG	22673
@VP	be promoted by the activation of the CPG	22677
@VP	promoted by the activation of the CPG	22680
@VP	to trigger the activation of the CPG below the lesion level of the spinal cord	22745
@VP	trigger the activation of the CPG below the lesion level of the spinal cord	22748
@VP	to effectively promote functional recovery in acute or sub-acute SCImodels	22923
@VP	effectively promote functional recovery in acute or sub-acute SCImodels	22926
@VP	are meaningful	23198
@VP	receiving full treatments	23306
@VP	is a remarkable recovery of locomotor function	23344
@VP	dragging or stepping phases before treatment	23500
@VP	to consistently plantar stepping with body-weight support	23632
@VP	consistently plantar stepping with body-weight support	23635
@VP	stepping with body-weight support	23656
@VP	stepping	23800
@VP	shows the course of functional recovery of a representative case	23817
@VP	stepping cycle	23919
@VP	indicating a critical progress for ratswith chronic spinal injury in neurology	23984
@VP	demonstrated by recovering behaviors -LRB- Dunlop , 2008 -RRB-	24458
@VP	induced by intense repetitive training and locomotor training	24568
@VP	are not fully understood	24630
@VP	fully understood	24638
@VP	plays a major role -LRB- Lynskey et al. , 2008 -RRB-	24693
@VP	to restore locomotion after thoracic SCI	24983
@VP	restore locomotion after thoracic SCI	24986
@VP	remains undamaged after contusion injury in T10	25407
@VP	weightsupported stepping of hind limbs with left	25497
@VP	stepping of hind limbs with left	25513
@VP	occurs	25564
@VP	triggered by TANES -LRB- Zhang et al. , 2010 -RRB-	25682
@VP	promoted by TANES through the activation of CPG	25925
@VP	induced by TANES into permanent ability to walk , namely functional recovery	26047
@VP	to walk	26087
@VP	walk	26090
@VP	needs to be further investigated	26131
@VP	to be further investigated	26137
@VP	be further investigated	26140
@VP	further investigated	26143
@VP	detected by NF staining and P0-positive myelination	26377
@VP	tracing data	26626
@VP	may be related with the functional recovery	26741
@VP	be related with the functional recovery	26745
@VP	related with the functional recovery	26748
@VP	activates the CPG and sends signals	26819
@VP	activates the CPG	26819
@VP	sends signals	26841
@VP	resulting in supraspinal axon regeneration	27049
@VP	associated with hind limb locomotion	27428
@VP	associated with the activity-dependent plasticity below the level of injury site	27825
@VP	did not have their BBB scores	28332
@VP	have their BBB scores	28340
@VP	lacking effective activity-dependent plasticity induced by locomotor training	28627
@VP	induced by locomotor training	28675
@VP	do not necessarily result in improvement of motor function	28763
@VP	result in improvement of motor function	28782
@VP	mentioned above	29017
@VP	promoted by TANES through the activation of CPG -LRB- Zhang et al. , 2010 -RRB-	29094
@VP	received only TANES but no basic treatments -LRB- SCI+TANES -RRB-	29189
@VP	tracing	29355
@VP	are not significantly different from the control animals	29363
@VP	is moderate in promoting functional recovery in rats with chronic SCI	29824
@VP	promoting functional recovery in rats with chronic SCI	29839
@VP	been proved by some cases in a recent clinical trial -LRB- Schalow , 2008 -RRB-	29914
@VP	proved by some cases in a recent clinical trial -LRB- Schalow , 2008 -RRB-	29919
@VP	promoted by the activation of CPG	30219
@VP	renders the injured rat permanent ability to walk	30498
@VP	to walk	30540
@VP	walk	30543
@VP	may be related with the improvement of motor behavior	30619
@VP	be related with the improvement of motor behavior	30623
@VP	related with the improvement of motor behavior	30626
@VP	would shed light to the study of chronic SCI	30686
@VP	shed light to the study of chronic SCI	30692
@VP	achieving improvement in functional outcomes in patients with chronic SCI	30774
@VP	4	30850
@VP	were used for this study	30950
@VP	used for this study	30955
@VP	received contusion injury and were randomly divided into 4 groups	31110
@VP	received contusion injury	31110
@VP	were randomly divided into 4 groups	31140
@VP	randomly divided into 4 groups	31145
@VP	to get a baseline of the locomotor behavior	31261
@VP	get a baseline of the locomotor behavior	31264
@VP	received TANES starting at 7 weeks after contusion injury until 22 weeks	31339
@VP	starting at 7 weeks after contusion injury until 22 weeks	31354
@VP	received basic treatments -LRB- BT -RRB- 6 weeks after contusion injury	31444
@VP	include scar ablation and LP/OEC transplantation as in our previous study	31528
@VP	received basic treatments followed by TANES	31640
@VP	transcardially perfused with phosphate-buffered 4 % paraformaldehyde	31840
@VP	survived the contusion or regenerated behind the injury site	31971
@VP	survived the contusion	31971
@VP	regenerated behind the injury site	31997
@VP	were used for retrograde tracing with fast blue at the end of the experiment	32061
@VP	used for retrograde tracing with fast blue at the end of the experiment	32066
@VP	tracing with fast blue at the end of the experiment	32086
@VP	were allowed to survive for one more week	32289
@VP	allowed to survive for one more week	32294
@VP	to survive for one more week	32302
@VP	survive for one more week	32305
@VP	used for transplantation	32685
@VP	described previously	32749
@VP	was isolated from the nasal septum of a donor Long -- Evans rat	32823
@VP	isolated from the nasal septum of a donor Long -- Evans rat	32827
@VP	was placed in Dispase II -LRB- Roche -RRB- for 35 -- 40 min at 37 °C	32888
@VP	placed in Dispase II -LRB- Roche -RRB- for 35 -- 40 min at 37 °C	32892
@VP	was then gently removed using forceps thereby exposing the LP	32970
@VP	removed using forceps thereby exposing the LP	32986
@VP	using forceps thereby exposing the LP	32994
@VP	thereby exposing the LP	33008
@VP	was cut into 1.0 × 1.0 mm squares and kept in L-15 on ice until transplant	33061
@VP	was cut into 1.0 × 1.0 mm squares	33061
@VP	cut into 1.0 × 1.0 mm squares	33065
@VP	kept in L-15 on ice until transplant	33096
@VP	were isolated from the LP of adult Long	33139
@VP	isolated from the LP of adult Long	33144
@VP	outlined elsewhere -LRB- Au and Roskams , 2002 -RRB-	33223
@VP	was then sequentially passed 3 times through 22	33430
@VP	sequentially passed 3 times through 22	33439
@VP	needles into growth medium	33491
@VP	spun at 400 × g , and plated in growth	33519
@VP	spun at 400 × g	33519
@VP	plated in growth	33538
@VP	plating for 24 h	33600
@VP	were removed	33637
@VP	removed	33642
@VP	were applied to the culture	33666
@VP	applied to the culture	33671
@VP	were grown for an additional 4 -- 7 days until nearly confluent	33704
@VP	grown for an additional 4 -- 7 days until nearly confluent	33709
@VP	may contain some contaminated Schwann cells	33869
@VP	contain some contaminated Schwann cells	33873
@VP	contaminated Schwann cells	33886
@VP	were collected and frozen in liquid nitrogen in working aliquots	33914
@VP	collected and frozen in liquid nitrogen in working aliquots	33919
@VP	described before -LRB- Zhang et al. , 2000 -RRB-	34129
@VP	clamping the spinous process at vertebra thoracic -LRB- T -RRB- level T7 and T10	34286
@VP	was performed on T8 and T9	34385
@VP	performed on T8 and T9	34389
@VP	were exposed with the dura mater intact	34449
@VP	exposed with the dura mater intact	34454
@VP	was dropped down on spinal cord segment T10 from a height of 25 mm	34510
@VP	dropped down on spinal cord segment T10 from a height of 25 mm	34514
@VP	was covered with a piece of adipose tissue	34607
@VP	covered with a piece of adipose tissue	34611
@VP	described previously	34716
@VP	was employed to relieve the pain for the first two days after injury/surgery	34815
@VP	employed to relieve the pain for the first two days after injury/surgery	34819
@VP	to relieve the pain for the first two days after injury/surgery	34828
@VP	relieve the pain for the first two days after injury/surgery	34831
@VP	administered to prevent possible infection in the wound and bladder for one week	34941
@VP	to prevent possible infection in the wound and bladder for one week	34954
@VP	prevent possible infection in the wound and bladder for one week	34957
@VP	emptied by hand twice a day until adequate spontaneous voiding returned	35055
@VP	returned	35118
@VP	was paid to keep the body skin dry	35138
@VP	paid to keep the body skin dry	35142
@VP	to keep the body skin dry	35147
@VP	keep the body skin dry	35150
@VP	was used daily for one week to prevent dehydration	35221
@VP	used daily for one week to prevent dehydration	35225
@VP	to prevent dehydration	35249
@VP	prevent dehydration	35252
@VP	checked daily during the first two weeks after surgery and once a week afterward	35304
@VP	described before -LRB- Zhang et al. , 2007a -RRB-	35550
@VP	was reopened	35675
@VP	reopened	35679
@VP	was exposed without cutting the dura	35727
@VP	exposed without cutting the dura	35731
@VP	cutting the dura	35747
@VP	connected to a microinjector , which was fixed in a stereotaxic instrument	35873
@VP	was fixed in a stereotaxic instrument	35909
@VP	fixed in a stereotaxic instrument	35913
@VP	rose Bengal within the cavity was allowed to diffuse for 5 min after injection	35952
@VP	was allowed to diffuse for 5 min after injection	35982
@VP	allowed to diffuse for 5 min after injection	35986
@VP	to diffuse for 5 min after injection	35994
@VP	diffuse for 5 min after injection	35997
@VP	To prevent unnecessary damage by the heating source from the halogen light	36149
@VP	prevent unnecessary damage by the heating source from the halogen light	36152
@VP	described previously	36475
@VP	connecting to a Hamilton syringe prior LP delivery	36660
@VP	was incised longitudinally	36740
@VP	incised longitudinally	36744
@VP	was made with an 11 blade to expose the lesion cavity	36851
@VP	made with an 11 blade to expose the lesion cavity	36855
@VP	to expose the lesion cavity	36877
@VP	expose the lesion cavity	36880
@VP	were carefully delivered into the lesion cavity	36936
@VP	delivered into the lesion cavity	36951
@VP	put on the dura and ready to tighten up immediately after LP delivery	37102
@VP	to tighten up immediately after LP	37128
@VP	tighten up immediately after LP	37131
@VP	were closed with proper sutures , respectively	37198
@VP	closed with proper sutures , respectively	37203
@VP	made by Quan-Ri-Kang Company in China	37482
@VP	has been demonstrated no risk	37524
@VP	been demonstrated no risk	37528
@VP	demonstrated no risk	37533
@VP	was performed as described previously -LRB- Zhang et al. , 2010 -RRB-	37909
@VP	performed as described previously -LRB- Zhang et al. , 2010 -RRB-	37913
@VP	described previously -LRB- Zhang et al. , 2010 -RRB-	37926
@VP	put in an open field -LRB- plastic swimming pool with a diameter of 4 ft -RRB-	38009
@VP	was then connected to the instrument with two electrodes	38094
@VP	connected to the instrument with two electrodes	38103
@VP	entered the rat 's tail	38181
@VP	started tomove extensively and alternatively	38224
@VP	stand up , step	38292
@VP	walk around the open field during the stimulation	38323
@VP	To prevent possiblemuscle fatigue due to the over movement of the leg muscle	38374
@VP	prevent possiblemuscle fatigue due to the over movement of the leg muscle	38377
@VP	was limited to 40 -- 60 steps per minute by modulating the stimulating strength	38482
@VP	limited to 40 -- 60 steps per minute by modulating the stimulating strength	38486
@VP	modulating the stimulating strength	38523
@VP	lasted 20 min per session , 5 sessions a week , for a total of 15 weeks	38587
@VP	were collected 1 day , 3 days , 7 days post-injury and once aweek afterward	38905
@VP	collected 1 day , 3 days , 7 days post-injury and once aweek afterward	38910
@VP	was made weekly for each rat	39038
@VP	made weekly for each rat	39042
@VP	reviewed carefullywith the help of slowmotion video records	39110
@VP	combining the BBB paper record with the results of the video record review	39229
@VP	were digitized	39597
@VP	digitized	39602
@VP	was reconstructed	39638
@VP	reconstructed	39642
@VP	were analyzed at the end of the experiment	39684
@VP	analyzed at the end of the experiment	39689
@VP	was used as a standard for comparison with other rats with different treatments	39782
@VP	used as a standard for comparison with other rats with different treatments	39786
@VP	separated into beginning , middle ,	39941
@VP	tracing The retrograde tracing with fast blue	40078
@VP	tracing with fast blue	40101
@VP	was employed to identify neurons in the cortex and brainstem with their axons	40124
@VP	employed to identify neurons in the cortex and brainstem with their axons	40128
@VP	to identify neurons in the cortex and brainstem with their axons	40137
@VP	identify neurons in the cortex and brainstem with their axons	40140
@VP	survived and growing into and behind the injury site	40202
@VP	survived	40202
@VP	growing into and behind the injury site	40215
@VP	was re-opened	40360
@VP	was exposed	40394
@VP	exposed	40398
@VP	attached to a 10 μlmicroinjector , which was fixed in a stereotaxic instrument	40592
@VP	was fixed in a stereotaxic instrument	40631
@VP	fixed in a stereotaxic instrument	40635
@VP	tracing	40687
@VP	were transcardially perfused with phosphate-buffered 4 % paraformaldehyde	40704
@VP	perfused with phosphate-buffered 4 % paraformaldehyde	40724
@VP	were removed	40801
@VP	removed	40806
@VP	being immersed in 20 % sucrose in 0.1 M phosphate buffer	40867
@VP	immersed in 20 % sucrose in 0.1 M phosphate buffer	40873
@VP	was transversely cut with a cryostat	40973
@VP	cut with a cryostat	40990
@VP	were mounted and coverslipped on glass slides	41036
@VP	mounted and coverslipped on glass slides	41041
@VP	were observed under a fluorescence microscope	41095
@VP	observed under a fluorescence microscope	41100
@VP	labeled neuron	41163
@VP	was plotted in order to avoid counting the same neuronmore than once	41178
@VP	plotted in order to avoid counting the same neuronmore than once	41182
@VP	to avoid counting the same neuronmore than once	41199
@VP	avoid counting the same neuronmore than once	41202
@VP	counting the same neuronmore than once	41208
@VP	were separately counted for each rat	41457
@VP	counted for each rat	41473
@VP	were removed and fixed in the identical fixative overnight	41581
@VP	removed and fixed in the identical fixative overnight	41586
@VP	were obtained from the middle of injury epicenter and stained routinely	41743
@VP	were obtained from the middle of injury epicenter	41743
@VP	obtained from the middle of injury epicenter	41748
@VP	stained routinely	41797
@VP	deparaffinized in xylene	41910
@VP	rehydrated in a series of ethanols and distilled water finally	41939
@VP	To quench the endogenous peroxidase	42101
@VP	quench the endogenous peroxidase	42104
@VP	was added -LRB- 60 min at RT -RRB- to the tissue to blocknon-specific antigens	42321
@VP	added -LRB- 60 min at RT -RRB- to the tissue to blocknon-specific antigens	42325
@VP	-LRB- 60 min at RT -RRB- to the tissue	42331
@VP	was visualized by incubating in 3,3 ′	42730
@VP	visualized by incubating in 3,3 ′	42734
@VP	incubating in 3,3 ′	42748
@VP	dehydrated	42870
@VP	cleared , and coverslipped after counter-staining with hematoxylin	42882
@VP	cleared	42882
@VP	coverslipped after counter-staining with hematoxylin	42895
@VP	counter-staining with hematoxylin	42914
@VP	were treated similarly , except the lack of the primary antibody	42967
@VP	treated similarly , except the lack of the primary antibody	42972
@VP	Archelos , Austria -RRB- of Schwann cells	43276
@VP	Spared tissue is the remaining peripheral rim of spinal cord tissue	43542
@VP	is the remaining peripheral rim of spinal cord tissue	43556
@VP	contains spared fibers and is GFAP-positive -LRB- Figs. 5A , B -RRB-	43783
@VP	contains spared fibers	43783
@VP	spared fibers	43792
@VP	is GFAP-positive -LRB- Figs. 5A , B -RRB-	43810
@VP	Repaired tissue	43842
@VP	is a newly formed tissue from the dorsal lesion cavity at the injury site	43858
@VP	contains almost no astrocytes	44175
@VP	is GFAP-negative	44216
@VP	repaired tissues and lesion cavities	44423
@VP	were separately measured	44460
@VP	separately measured	44465
@VP	were stained with hematoxylin and eosin	44508
@VP	stained with hematoxylin and eosin	44513
@VP	were expressed as Mean ± SEM	44778
@VP	expressed as Mean ± SEM	44783
@VP	were carried out	44841
@VP	carried out	44846
@VP	can be found in the repaired tissue	44998
@VP	be found in the repaired tissue	45002
@VP	found in the repaired tissue	45005
@VP	obtained from the injury epicenter	45181
@VP	were used to evaluate the trend of axonal regeneration	45216
@VP	used to evaluate the trend of axonal regeneration	45221
@VP	to evaluate the trend of axonal regeneration	45226
@VP	evaluate the trend of axonal regeneration	45229
@VP	described previously	45394
@VP	were used for the counting	45531
@VP	used for the counting	45536
@VP	spared tissue on the transverse sections at the injury epicenter	45632
@VP	were counted -LRB- n ≥ 4 each group -RRB-	45697
@VP	counted -LRB- n ≥ 4 each group -RRB-	45702
@VP	myelinated by Schwann cells -LRB- Zhang et al. , 2007a -RRB-	45816
@VP	contains the spared tissue	45885
@VP	counted P0-positive myelin sheaths within the counting area	45925
@VP	were included as a total number for each case	45985
@VP	included as a total number for each case	45990
@VP	were expressed as Mean ± SEM	46087
@VP	expressed as Mean ± SEM	46092
@VP	were expressed as Mean ± SEM	46164
@VP	expressed as Mean ± SEM	46169
@VP	were averaged to yield one score for each time point	46272
@VP	averaged to yield one score for each time point	46277
@VP	to yield one score for each time point	46286
@VP	yield one score for each time point	46289
@VP	repaired tissue , lesion cavity and spared tissue	46526
@VP	repaired tissue , lesion cavity	46526
@VP	spared tissue	46561
@VP	repaired tissue , lesion cavity and spared tissue between groups	46730
@VP	repaired tissue , lesion cavity	46730
@VP	spared tissue between groups	46765
@VP	were collected and averaged for each group	46906
@VP	collected and averaged for each group	46911
@VP	were performed using one-way ANOVAs	46980
@VP	performed using one-way ANOVAs	46985
@VP	using one-way ANOVAs	46995
@VP	labeled with fast blue tracer	47025
@VP	were counted nuclei by nuclei	47055
@VP	counted nuclei by nuclei	47060
@VP	were carried out by one-way ANOVAs	47202
@VP	carried out by one-way ANOVAs	47207
@VP	performed for overall significance followed by a post hoc LSD Student 's t test	47290
@VP	followed by a post hoc LSD Student 's t test	47325
@VP	were considered significant if p < 0.05	47382
@VP	considered significant if p < 0.05	47387
@VP	was analyzed using linear regression	47515
@VP	analyzed using linear regression	47519
@VP	using linear regression	47528
